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Abstract
According to the World Health Organization (WHO) report in 2019, cardiovascular
diseases (CVD) cause 52% of all illness-related deaths globally and are considered to be
the second most common cause of death in Canada. CVD is also estimated to cost the
Canadian economy about $21.2 billion in direct and indirect costs. With these figures, it is
vital to develop the most effective and accurate methods and tools to diagnose accurately
CVD and their causes. One of the promising tools for accurate diagnostic and therapeutic
of CVD is the integrated Positron Emission Tomography (PET) and Magnetic Resonance
Imaging (MRI) PET/MRI technology, which has successfully been used in cardiovascular
imaging. The PET/MRI system provides low exposure of radioactive and ionized radiation
which is advantageous over the standard technology of integrated PET/computed
tomography (CT) PET/CT system.

However, since the integrated PET/MRI technology

was first introduced in 2010 for clinical use, its hardware attenuation correction (AC) still
presents a challenge, which is crucial to achieving accurate PET quantification in cardiac
imaging. Additionally, for cardiovascular PET/MRI the system still requires a higher
temporal and spatial resolution radio frequency (RF) phased array for faster imaging
sessions of cardiac patient, without loss of MRI image quality, while minimizing photon
attenuation.
This thesis introduces a novel 32-channel RF phased array, prospectively-designed for
simultaneous PET/MRI cardiovascular imaging. The phased array’s MR imaging quality
parameters, including, geometry factor (g-factor), noise correlation coefficient (NCC) and
signal-to-noise ratio (SNR) were measured using a phantom and three healthy volunteers
and the results were compared against currently used arrays.

i

Post-assessing the MR image quality, the array was evaluated for 511keV PET photon
attenuation. The evaluation is carried out using a NEMA procedure and phantom, in which
contrast recovery (CR), background variation (BV) and contrast-to-noise ratio (CNR) were
measured and compared. Furthermore, the thesis presents a static radioactive source as a
novel method for accurate attenuation correction (AC) of hardware (i.e. patient table) used
during cardiovascular imaging.
In summary, assessing both MRI and PET performances of the novel array, resulted in
MRI SNR improvements of >30% at different acceleration factors (R > 2), compared to
the standard array. In the meantime, the PET counts loss caused by the novel array was
significantly lower (p=0.001) than those caused by the standard arrays. The novel AC
method produced a hardware AC map with global counts loss of -0.7% in comparison to 4.3% as produced by the CT-based method.

In conclusion, both the novel array and the hardware AC method presented here, enable
the acquisition of high temporal (fast imaging session) and spatial (image quality)
resolutions by the MRI system, together with accurately quantifying the PET standardizeduptake-value (SUV). The method and tools presented in this work have been evaluated for
simultaneous PET/MRI cardiovascular imaging, and hence they can be effectively used to
study CVD and their causes accurately in a shorter imaging time. Therefore, the
improvements reported in this thesis contribute to better understand the CVD and
potentially lowering the economic burden around them. The impact of these improvements
is broad, since they may be applied to PET/MRI imaging of brain, prostate and other
organs.
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Summary for Lay Audience
Treatment of diseases is only possible if their causes and developments are understood. In
medical imaging, understanding the disease is the purpose behind developing
methodologies and tools that can be used during this process. Two of the imaging tools
used in understanding cardiac diseases are the positron emission tomography (PET) and
magnetic resonance imaging (MRI). Both have been integrated into one scanner namely
PET/MRI to complement each other, which provides excellent data to study heart
functions, disease causes and disease development. In hybrid PET/MRI technology, the
MRI is free of radiation and provides excellent image contrast, while the PET system is
used for measuring tissue functions, both of which are necessary for diagnosis.
The PET/MRI technology is fairly new (only 10 years old), and is powerful, because it
reduces the study time by half especially for patients requiring imaging with both PET and
MRI. However, due to the integration of the PET and MRI into one, hybrid PET/MRI,
several challenges become apparent which need to be addressed. One of these challenges
is the inaccurate counts of radioactivity in the PET image. This happens when the
radioactivity is blocked by hardware parts which are present in the scanner during imaging.
Another challenge is to obtain high-resolution MRI images and reduce the scanning time,
so a tool (named a RF phased array) is required to achieve these high-resolution images
and shorten the time of the imaging session for the patient. This research work addresses
both the accurate counting of the radioactivity and the RF phased array. My research work
provided an RF array that does not block radioactivity, while also being capable of
shortening the imaging time to a tolerable level for the cardiac patient. The research work
also provided a new approach to correct for inaccurate counts caused by other parts in the

iv

PET/MRI system. The author anticipates that these improvements and developments will
enhance accurate diagnosis and the study of cardiac diseases using the PET/MRI platform.
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Chapter 1
1

Introduction

1.1

Background

1.1.1

Motivation

Cardiovascular diseases (CVD) cause 31% of all illness-related deaths globally and are
considered to be the second cause of death in Canada1,2. According to the 2018 Health
Canada report2, CVD is estimated to directly cost the Canadian economy about $2.8 billion
per year3, while the American Heart Association (AHA) reported a direct cost of $213.8
billion to the US economy4. The statistics data from 2012 and 2013, shows approximately
2.4 million adults Canadian (of age ≥ 20 years) suffer from ischemic heart disease, where
24.1% of them have history of an acute myocardial infarction, and 27.1% of them in the
age 40 or more, were living with heart failure5.
Although remarkable advancements in the prevention and management of heart disease
have been made in the last few decades, the burden remains high and sustained efforts are
needed to ensure early diagnostic and treatment6. As per the Canadian Heart and Stroke
Foundation (CHSF) report in 2016, while several diagnostic tests are well established to
identify heart failure caused by cardiovascular diseases, access to specialized services,
including advanced diagnostic methods, is very low. Therefore, CHSF recommendation to
healthcare providers was improve and facilitate such services which are required to achieve
early diagnosis for heart diseases including cardiovascular7. Given this current situation, it
is vital to develop the most effective and efficient methods and tools to diagnose accurately
cardiac diseases and their causes.
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Cardiovascular diseases are a collection of disfunctions of the heart and blood vessels, that
affect the heart and the brain1, and can be grouped into two categories. The first category
belongs to coronary artery diseases caused by deposition of plaques of fatty material on
inner arteries walls. This includes for example: a) coronary artery diseases of the blood
vessels of the heart which can cause myocardial infarction; b) diseases of the blood vessels
to the brain, known as cerebrovascular, which can cause ischemic stroke; and c) peripheral
arterial diseases which targets blood vessels supplying the arms and legs, which can result
in hypertension. The second category is the CVD caused by impairment or ailment of the
heart. This includes for example: a) cardiac arrhythmias, which are described as
abnormalities of rate or rhythm of the heart; b) abnormal heart muscle known as
cardiomyopathy; c) congenital heart disease, due to abnormality and/or defects of the heart,
from the time of birth8.
The diagnosis of heart diseases has come a long way since the invention of the
Electrocardiography by Waller 130 years ago9. Since then, different imaging modalities
are used for clinical diagnostics of cardiovascular diseases such as, nuclear cardiology10,
echocardiography (ECG)11, magnetic resonance imaging (MRI)12, cardiac computed
tomography (CT)13,14, single photon emission computed tomography (SPECT)15, positron
emission tomography (PET)16 and coronary angiography17. Each modality has greatly
broadened the capability of understanding some of the CVD, however, each imaging
modality is limited in only providing part of the needed information at the anatomical
functional and molecular level. Understanding the dynamics of cell biology to the
molecular level is a key to understanding and treating the conditions associated with CVD.
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This has led to the integration of complementing-modalities into the hybrid diagnostic
platform, like the PET/MRI.
For almost a decade, the integrated hybrid PET and MRI (PET/MRI) systems have been
used successfully in cardiovascular studies18, with growing concerns that this platform will
improve timely diagnosis of cardiac diseases19-21. However, hybrid PET/MRI still lacks a
few critical components before reaching reliable and accurate measurements of cardiac
anatomy, function, metabolism and cellular/molecular, which are still challenging22-26.
Some of the challenging components are related to hardware and software of this hybrid
platform. This includes: a) radio frequency phased array capable of fast acquisition of high
resolution MRI images using 3D imaging and 2D acceleration; b) software including MR
imaging pulse sequences capable of achieving fast acquisitions and high temporal
resolutions; c) software algorithms for the reconstruction of PET images free of motions
artifacts; and d) techniques and methodologies to correct for attenuated photons in PET
images caused by the presence of both the patient body and, the hardware used for the
PET/MRI simultaneous acquisitions.
It becomes therefore apparent, that addressing these technical challenges associated with
the integration of PET/MRI modalities may significantly enhance the role of this hybrid
platform in reliable and accurate cardiac diagnosis. The goal of the research reported in
this thesis was to improve both, PET and MRI images of the heart, on hybrid PET/MRI
systems. Three objectives supporting this overall goal were set, objective 1- provide a
novel concept of RF phased array for the hybrid PET/MRI platform, capable of achieving
high spatial (1mm) and temporal resolutions (improving upon current vendors array).
Objective 2- Implement a novel concept of the RF phased array that provides no-to-
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minimum photon attenuation (less than 5%). Objective 3- develop a novel hardware
attenuation correction method for accurate PET quantification. The author anticipates that
through these two novel approaches to address these three objectives, better and less
expensive approaches to heart imaging will emerge increasing heart patient access to this
hybrid technology.
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1.1.2

Thesis outline

The thesis is structured so that, each topic is gradually reviewed from its basics to today’s
cutting-edge-research status, in order to provide the reader with a wider understanding of
each topic and its relationship to the objectives.

In chapter one, the introduction, the

principles of each imaging modality related to this work are reviewed separately and a brief
review of each modality temporal and spatial resolution is described. First, the principle of
computed tomography, from theory to creating an image, is explained. This is followed by
reviewing the principles of magnetic resonance imaging and the process of acquiring an
image. The introduction also discusses the principles of RF phased arrays, and their use in
parallel imaging to produce fast and high-resolution MR images. This also includes a
review of the currently used RF phased arrays in cardiovascular MR imaging. Thereafter,
the principles behind positron emission tomography are explained followed by a review of
the challenges the PET modality faces, such as the attenuation effect, including their causes
and approaches to resolve such effects. Integrated imaging modalities, or often referred to
as hybrid systems, such as PET/MRI, is discussed with a focus on cardiovascular diseases.
Afterwards, the photon attenuation challenge in an integrated PET/MRI system is visited,
including a review of the current approaches and methods to address this issue. The
introduction is then concluded by describing the relationship between hardware
components of the hybrid PET/MRI system and the accuracy of diagnosis in cardiovascular
diseases. By the end of chapter one, research questions with the thesis objectives and means
of achieving them, are articulated.
Chapter two is a published work of objective one of the thesis, which addresses the imaging
quality of a novel prospectively-designed 32 RF receivers phased array for cardiac
5

PET/MRI system. In this chapter, a comprehensive review of current devices and their pros
and cons are considered. Measurements of quality parameters of images produced by the
phased array are reported and compared to other available arrays.
Chapter three is the work published on the PET imaging performance for the same phased
array which covers the second objective of the thesis. The novel phased array performance
under PET environment is described in terms of the quality parameters for PET imaging,
such as, contrast recovery, background variations and contrast-to-noise ratio. Comparison
of these parameters of the novel array with two vendor arrays are reported demonstrating
statistical significance improvements.
In chapter four a novel approach of hardware attenuation correction is described in detail,
which covers the third objective of the thesis and is currently under peer review by a
scientific journal. The theory behind attenuation correction using a static radioactive
transmission source is explained, together with the validation technique of the theory. This
chapter also demonstrates an application of the novel method in cardiovascular hybrid
PET/MRI imaging.
Chapter five, summarizes the findings from the work reported in chapters two, three and
four. An inclusive conclusion on the goal of the thesis is then presented, followed by
elaboration on the significance of the research and its contribution to PET/MRI
cardiovascular imaging. Finally, future work and potential applications of the novel work
of the thesis, are suggested.
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1.2

Principles of selected imaging modalities

1.2.1
1.2.1.1

CT imaging modality
Principle, data acquisition and image reconstruction

The CT concept was first introduced by Godfrey Hounsfield in 197327, while its
mathematical principle was developed by Radon in 1917. A CT modality system simply
consists of a rotating x-ray source(s) and its detector(s) at the opposite side, where the
object to be imaged is positioned between the source and the detector. A CT acquisition
measurement is made by the ray (from an x-ray) passing through the object, where each
point produced in the image represents the attenuation property of that region of the
object28. A 2-dimentional (2D) image can only be acquired through the simultaneous
rotation of the x-ray source and detector, so both posteroanterior and lateral projections can
be acquired. For 3D acquisition, the scanner adapts the technique of moving the patient
bed in superior-inferior direction or vise versa, which results in a helical-shaped projection.
Image reconstruction for CT modality has historically used a filtered back-projection
algorithm29, but in recent years iterative methods are being used more, resulting in reduced
radiation dose and improved signal to noise ratio. Then, another algorithm interpolates the
data into a series of planar images to account for the helical effect. The reconstructed CT
image is scaled, according to Hounsfield, so that air radiodensity is equivalent to -1000
Hounsfield units (HU), while water radiodensity is 0 HU and bone density is >100 HU.
Therefore, each voxel raw data V(x,y) in a 2D matrix, is calculated from the relation in
equation 1:
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𝑉(𝑥, 𝑦) = 1000 ×

𝜇(𝑥,𝑦)− 𝜇𝑤𝑎𝑡𝑒𝑟
𝜇𝑤𝑎𝑡𝑒𝑟

(1)

Where µwater is the attenuation coefficient of water and µ(x,y) is the attenuation coefficient
of material at voxel V(x,y).

1.2.1.2

CT image artifacts

CT modality is the highest in temporal (83–135 ms) and spatial (0.5–0.625mm) resolutions
in comparison to PET and MRI30. Nevertheless, artifacts in images produced from CT
modalities exists, such as partial volume averaging, motion artifact31, and beam
hardening32. The most related artifact to the work of this thesis is the beam hardening.
When low energy x-ray is attenuated by a high-density and high atomic number (Znumber) material, the x-ray energy distribution is skewed towards high energies as lower
energies are preferentially absorbed. This increase in the average energy of x-ray
distribution is known as beam hardening. Beam hardening causes more photons to be
detected (artificially) than would be detected if the x-ray energy distribution had not been
changed. This results in dark streaks artifacts in the image data. In figure 1-1, dark streaks
are visible in the CT image as a result of beam hardening, which in this example produced
by the RF metal components in a RF receivers’ array. Beam hardening can also cause poor
quality and inaccurate attenuation coefficient maps, which will be discussed later in section
1.2.3.6. In a single energy CT scanner, beam hardening correction technique, such as Bow
tie filters, is normally included and applied before reconstruction. However, these
correction techniques are not adequate to correct for higher electron densities materials, as
in metals found in RF arrays.
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Figure 1-1: Illustration of beam hardening in CT image.

CT image of a posterior part of RF array and patient table containing high density
material

1.2.1.3

Dual-energy Computed Tomography

Dual-energy computed tomography (DECT) scanners can perform imaging at two different
energy levels (figure 1-2), either by rapidly switching one x-ray tube voltage between low
(i.e 70kVp) and high (i.e 140kVp) energies33,34; or by incorporating two x-ray tubes each
for the two energies35. In attenuation correction, DECT reduces beam hardening effects
by scanning at two different energies32,36, by generating virtual monochromatic images,
however, they are known to be problematic because of the noise amplification produced36.
DECT reduces beam-hardening artefacts caused by materials with higher electron densities
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like iodinated contrast agents, however, it does not eliminate the beam hardening for higher
Z material like metals 37.
Although the CT technology has impressively evolved since it was first introduced in 1973,
still ionizing radiation dose to the patient remains a drawback38.

Figure 1-2 Illustration of two approaches of currently available Dual-energy CT
scanners for dual acquisitions.

a

b

Dual Energy CT available for dual acquisitions; (a) single x-ray source alternating
rapidly between 140 and 70kVp energy; (b) simultaneous dual x-ray sources at each
energy level.
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1.2.2

1.2.2.1

MRI imaging modality

Principle of the MRI modality

The principle of signal detection and image creation in the MRI system is described as the
process of excitation and relaxation of a given nucleus. Excitation is the change of the
nucleus state from thermal equilibrium to a high energy state, while relaxation is simply
the return of the nucleus back from its high energy to thermal equilibrium state. As the
nucleus returns back to its thermal equilibrium (relaxation process), the signal is detected
to create an image. When the tissues are present in the magnetic field, provided by the
permanent magnet in the MRI system (fig 1-3), the nuclei have a net equilibrium
magnetization (𝑀0 ) and mostly are aligned with the static magnetic field 𝐵0 along the z
plane, and the net magnetization vector will have two components longitudinal (Mz) and
transvers (Mxy). At this state, the nuclei are precessing at their natural resonance frequency,
known as Larmor frequency (𝜔). The excitation happens by means of changing the nuclei
magnetization magnitude and direction from low energy state resulting in a net
magnetization in the transvers plane x and y (𝑀𝑥𝑦 ). The excitation requires applying a
secondary electromagnetic field (𝐵1) at the exact precessing frequency of the nuclei for a
given magnetic field strength which is achieved using specially designed devices namely
RF resonators (fig 1-3 b). The RF electromagnetic energy causes the nuclei to tip with a
certain degree (flip angle), that is proportional to the RF strength and duration of echo time
(TE), from longitudinal (z axis) to transvers planes (x, y axes) as in fig 1-4 -a. Therefore,
when a maximum transverse magnetization is desired, one must achieve 90° flip angle by
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the RF transmit (Tx) resonator tuned to the Larmor frequency of the targeted nuclei with a
known gyromagnetic ratio (γ), where the Larmor frequency is determined by the relation;
𝜔 = 𝛾𝐵0

(2)

After an RF pulse is applied, nuclei precession decay in the transverse plane in a short time
which is known as spin-spin relaxation or T2 (fig 1-4 -b), while the nuclei also relax back
to their lower energy state along the z-axis, where Mz grows in a longer time known as spin
lattice relaxation or T1.
The mathematical relationship describing the two process of T2 and T1 relaxation over time
(𝑡) with respect to transverse and longitudinal components of magnetizations, are described
respectively in equations 3 and 4:

𝑀𝑥𝑦 (𝑡) = 𝑀0 𝑒 −𝑡/𝑇2

(3)

𝑀𝑧 (𝑡) = 𝑀0 (1 − 𝑒 −𝑡/𝑇1 ) (4)

The RF Tx part of the resonator excites the nuclei, while the RF receiver part (Rx) picks
up the induced voltage from the nuclei during the process of relaxation (fig 1-4 -c), and
results in a signal in the form of free induction decay (FID) (fig 1-5 a). FID signal is
therefore produced from a complete excitation and relaxation, and by repeating (repetition
time TR) this process many times resulting in an image.
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Figure 1-3 Illustration of the structure of the main components in a generic PET/MRI
system.

The illustration of the system showing; body RF resonator (green), the set of gradient
coils (Gx, Gy and Gz) perpendicular to each other’ s plane, and a PET detector ring
(blue) between two left and right sets of gradient coils. (This illustration does not
represent the exact design)
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Figure 1-4 Illustration of excitation process of nucleus by RF resonator.

The excitation for a nucleus from low energy (thermal net equilibrium) along z-axes
to high energy state with a net transverse magnetization Mxy. b) transverse
magnetization precessing in the x,y plane decreases over time (T2); c) Relaxation
process from transverse to longitudinal magnetization with the spiral as a
representation of the net magnetization vector with net precession (T1 and T2).

Figure 1-5 Illustration of received signal from RF receiver corresponding to the
FID.
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A set of controllable gradient coils produce electromagnetic fields with varied intensity
along the x, y and z axes of the MRI scanner (fig 1-3). The gradient coils are capable of
producing a magnetic field gradient along any single plane or combined planes, in order to
achieve the desired orientation of the magnetic field gradient. They locally alter the
strength of the main magnetic field B0, which changes the precessing frequency between
slices and hence they can be used for slice selection, phase-encoding and frequency
encoding (read-out). Each gradient coil is named after its annotation i.e. Gx is the x-gradient
along x axis, and enables sagittal imaging, while Gz is z-gradient along the z axis, and
allows for axial imaging, and so on.

1.2.2.2

Image acquisition and reconstruction

Acquisition of MR image follows the set of processes described above (excitation,
relaxation, localization /selection and sampling/writing the data), which are organised in a
precise sequential order, known as a pulse sequence. The most fundamental pulse sequence
in MRI are the gradient echo (GRE) sequence and spin echo (SE) sequence, both from
which many other sequences were developed, i.e. balanced steady-state free precession
sequence (balanced-SSFP) shown in figure 1-6-a and is used in chapter 2.
For a 2D image, a single FID signal is acquired in the time domain and recorded as complex
values, namely k-space, representing both magnitude and phase of the MRI signal, which
is arranged in a 2D matrix. The 2D matrix containing data collected in k-space is filled
during acquisition with the frequency encoded data from k-x to k+x direction, while the
phase encoding data are filled from k-y to k+y direction, in a Cartesian fashion (figure 1-7 b). However, there are other ways to fill the k-space, such as spiral acquisition, radial
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acquisition etc.

To create the 2D image in laboratory spatial co-ordinates one must

transform the 2D k-space data using the 2D Fourier relation shown in (eq. 5).
+∞

𝑮(𝒌𝒙 , 𝒌𝒚 ) = ∬−∞ 𝒈(𝒙, 𝒚)𝒆−𝟐𝝅𝒊𝒌𝒙𝒙 𝒆−𝟐𝝅𝒊𝒌𝒚𝒚 𝒅𝒙 𝒅𝒚

(5)

Where 𝒈(𝒙, 𝒚) is function of real variables of x and y known as Fourier conjugates, and
𝑮(𝒌𝒙 , 𝒌𝒚 ) is the complex 2 D Fourier transform of 𝒈(𝒙, 𝒚)
Figure 1-6 Illustration of a pulse sequence of a balanced-SSFP (TrueFISP) that is
commonly used in cardiac MR imaging.
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Figure 1-7 Illustration of 2D Cartesian k-space matrix that produces a 2D image using
2D-FFT.

Each line is filled during each TR along the frequency-encoding axis (Gx), where the
location of the lines with respect to y-axis depends on the phased encoding gradient
pulse (Gy). When all lines (solid and dashed) are filled, the k-space is fully sampled,
while skipping dashed lines would result in under-sampled k-space, which accelerates
the image acquisition and construction used in parallel imaging. If every other line is
skipped in the ky axis the acceleration factor R = 2 and acceleration is in one
dimension.

1.2.2.3

Temporal and spatial resolution for image quality

Although the temporal and spatial resolution achieved today by cardiac MRI, close to or
exceeds those provided by CT and PET imaging modalities30, imaging with MRI system
has continued to strive to achieve better spatial and temporal resolutions. Spatial resolution
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relates to the size of the voxel in the image, where, the smaller the achieved voxel size, the
higher spatial resolution, hence higher image detail. On the other hand, the temporal
resolution relates to how fast the data is acquired and an image is reconstructed. Achieving
both spatial temporal resolutions requires optimization of both the RF resonators and the
pulse sequence together with its associated image reconstruction algorithm. Relying on the
integrated body resonator in MRI system, the imaging is limited to one element that
transmits and the same element receives, which limits the ability to resolve details spatially
in the image. This also results in very long imaging times, due to the number of lines on kspace to be filled from only one element receiver. Therefore, to achieve spatial resolution,
beside optimising the pulse sequence, the approach of using RF resonator with multiple
elements, namely RF arrays, allows acquisition from large areas at the same time
(improved coverage)39.

Since small elements have intrinsically high sensitivity in

comparison to a large element, when employing many small elements, a larger volume in
the imaging field-of-view (FOV) is covered with high sensitivity40,41. Consequently, arrays
with multiple small elements with high sensitivity allow the achievement of higher spatial
resolution.

1.2.2.4

Parallel imaging

Efficiently acquiring the signals from several channels simultaneously requires a special
technique of imaging known as parallel imaging42,43. This is achieved using specially
designed pulse sequences matched to specific reconstruction algorithms, such as;
Sensitivity Encoding (SENSE)42, Simultaneous acquisition of spatial harmonics
(SMASH)43,44, or Generalized auto-calibrating partially parallel acquisitions (GRAPPA)45.
Parallel imaging has tremendously shortened the time of the acquisitions themselves and
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the time between one acquisition and the other46. It is therefore, with the combination of
pulse sequence modifications and, using multiple receiver element RF phased arrays39, that
high temporal and spatial resolutions can be achieved43,47. Other solutions for temporal
resolution in MRI are reported using rectangular small FOV, or using partial Fourier
transform reconstruction48,49, both of which the number of lines of k-space are reduced,
hence acquisition time and reconstruction time is shortened. This reduction of the
acquisition time due to a reduction in the number of acquired lines of the k-space is called
acceleration, and measured as the ratio of the unaccelerated acquisition time to the
accelerated acquisition time50,51. The technique of parallel imaging enhances the time
efficiency in filling k-space by utilizing the overlapping sensitivity profiles from multiple
RF elements to mathematically reconstruct the missing lines52. The technique is useful in
reducing the scan time in applications such as contrast enhanced cardiac MRI for
shortening the breath-hold53. Employing parallel imaging with sequences such as gradient
echo SSFP, known also as true fast imaging with steady-state precession (TrueFISP), can
achieve short acquisition time and high signal-to-noise ratio (SNR)54,55. However, the SNR
and image acceleration that can be achieved using parallel imaging is limited by the
geometric factor of the elements which is known as the g-factor56-58. SNR for a single
receiver element, is the ratio of induced signal to the root mean square of the thermal noise
voltage. SNR of an image from a single element, can therefore be estimated form the mean
signal divided by the standard deviation of the magnitude background noise of the same
image. However, in a phased array with multiple elements, noise from each element may
correlate causing a spatial variation (nonuniform noise) of the overall noise in the
composite image.

The noise correlation, and hence, noise variation (noise covariances
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matrix) must therefore be considered to accurately estimating SNR for phased arrays. In
addition, in parallel imaging with phased array, reducing number of k-space lines to
accelerate the acquisition results in the reduction of the FOV, which consequently causes
aliasing (superposition). To undo the signal superposition caused by combining elementssignals, each element sensitivity with its weight is used42. The sensitivity of each element
together with noise correlation are then computed to estimate the g-factor which can then
be used to determine the g-based SNR, namely, SNRg. In chapter 2, SNRg together with
SNR with no acceleration technique are used to evaluate the phased array MRI
performance at different acceleration factors.

1.2.2.5

Phased arrays

The concept of phased array in MRI refers to multiple receiver elements (sometimes also
called as channels) with the property of correcting the polarization of the received signal
simultaneously at each point, by the choice of phases and amplitudes when combining the
signals39,59.
One of the early demonstrations of the advantage of the phased array in cardiac MR
imaging has been reported at 1.5T with an overall enhancement of the SNR for the entire
heart59. Since then, several phased array resonators with a different number of channel
elements were developed50,51,60-62, with mainly two goals to achieve, these are: 1- highest
acceleration factor through increase of number of channels61, and 2- best geometrical
overlapping of the channels to reduce the g-factor51. Achieving these two goals allows for
the acquisition of a fast (temporal resolution), high SNRg, well spatially resolved image.
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Both g-factor and SNRg for an RF phased array must therefore be evaluated at each
acceleration factor to determine its suitability for parallel imaging. Therefore, the most
suitable RF phased array for parallel imaging is determined by the highest acceleration
factor without substantial degradation of the SNR, which depends on the gfactor56,58,60,63,64. In such evaluation the noise from each channel is measured and a
correlation between all channels is determined and arranged in a noise-correlation matrix
with its dimension equal to the number of the elements in the array65. As depicted in figure
1-8, the noise correlation matrix is used with the sensitivity map for each channel to
calculate the g-factor and hence the SNR at different acceleration factors42,63.
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Figure 1-8 Illustration of the process of calculating the SNRg of a multi-channel
phased array.

The process of calculating the g-factor and SNRg of a multi-channel phased array for
any given acceleration is shown, where R is the acceleration factor, and SNR0 is the
fully sampled image SNR. The method uses both k-space data of the signal (top) and
the noise.
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1.2.3

PET imaging modality

1.2.3.1

Radiotracers used in PET

When radioactive isotopes are arranged in a compound, such as

18

F-fluorodeoxyglucose

(FDG) with ability to be administered to the body, the glucose adds a metabolic property
to the compound. Therefore when administered it tends to attach itself to the glucose
metabolism in cells, and for certain organs as well as tumors more radiotracer are attached,
results in the FDG compound acting as a tracer and a label of the diseased cells66-68

1.2.3.2

Principle of PET modality

Radioactive isotopes such as

11

C,

15

O,

13

N, and

18

F decay by isotropically emitting

positively-charged particles (β+) namely, positrons69. Each positron released has kinetic
energy characteristic of the originating nucleus, which it loses during its interaction with
electrons (e-) from the surrounding matter. Once the positron has slowed down sufficiently,
final interaction between a positron (+) and an electron (-), annihilation of the electron
occurs and yields two photons radiating with energy of 511keV which is known as gamma
rays70 Emitted pair of photons from the annihilation process travel generally in opposite
directions (nearly 180°) of each other (figure 1-9), which gives the opportunity to detect
and confirm the annihilation event (also known as coincidence) using a pair of appropriate
detectors70.
The PET scanner contains a number of rings, where each ring includes a set of detectors
arranged in a circle and covers 360°, around the target-body to be imaged. The signal
acquired by the PET system is generated when an annihilation occurs and the two photons
are detected by a pair of detectors at opposite sides, simultaneously, on the same line, which
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is known as the line of response (LOR). PET detectors are array of scintillation crystals. In
the past the scintillation produced in the crystals by the 511keV gamma rays were detected
by a photo multiplier tube (PMT)70. However as PMT are sensitive to the magnetic field in
the hybrid PET/MRI system, they have been replaced by Avalanche photodiodes and
silicon photomultipliers71.
Figure 1-9 Illustration of annihilation coincidence event with two gamma-photons
travelling in opposite directions.

Annihilation coincidence event occurred when positron emitted from a decayed
nucleus of the radioactive tracer interacts with electron from the tissue. The positron
annihilates with the electron resulting into two gamma-photons travelling in opposite
directions.

Recorded coincidences from annihilation are classified into three main categories as shown
in figure 1-10; a) true coincidence, which occurs when one annihilation and two photons
are detected at opposite detectors within a specific time window; b) scatter coincidence,
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where one annihilation occurs, but one or two of the photons are scattered, and both are
detected, and; c) random coincidence, where two true coincidences occur resulting in an
artificial line of response (dashed blue line in figure 1-10-c), and only one coincidence (two
photons) are detected simultaneously.
Figure 1-10 Illustration of the type of coincidences occurs from photon emission in
PET.

a

b

c

Three type of coincidences occurs from photon emission in PET; a) true coincidence,
b) scatter coincidence, and; c) random coincidence. The solid blue line is the
annihilation path and the dashed blue line represents the calculated LOR.

1.2.3.3

PET Image reconstruction

The reconstruction of PET images from PET data involves two steps; first correcting for
factors affecting the quantification of coincidences and second the transformation from
digital signal to useful images. Only a brief description of each step will be described here,
except for attenuation correction which has different root causes and techniques of
correction, and therefore will be discussed separately.
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1.2.3.3.1

PET data correction

PET data from each LOR must be corrected for; 1- random and 2- scatter coincidences, 3variation of detectors efficiencies, 4- count loss due to dead-time, and 5- attenuation of
photons.
Correction of random coincidences may be reached by performing additional acquisition
with a time delay to only one of the detected signals. The time delay violates the condition
of detecting true coincidences and hence all detected coincidences in the additional
acquisition are random, which can be determined, and then removed from the PET data.
Correction of scattering effect in PET systems has been addressed by different scatter
correction models72-77, and found that quantitative accuracy of different type of scatter
correction techniques did not have a significant impact on the quantitative results78.
However, most used a model for scatter-correction that is based on an iterative
reconstruction-based scatter compensation approach, which is suitable also for threedimensional data76,79,80.
The variation of detector efficiencies causes variations in the image resolution and
sensitivity. These can be corrected by means of normalization, which is described as, the
number of detected coincidences by a pair of detectors in the data, divided by normalization
factor of that pair of detectors81. The normalization factor is simply the ratio between the
number of coincidences at each detector pair, from a uniform scan, and the average
coincidences from all pairs.
Another type of correction that must be performed on when using PET detectors in pulse
mode is the dead-time, which occurs due to loss of photon count. Since a finite time is
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needed between two photon interactions to produce a signal, if the second photon
interaction occur before the first photon interaction ends, the second photon is not counted.
The dead-time is normally addressed by applying either a paralyzable or non-paralyzable
model. The paralyzable model assumes that a part of the data processing is performed on
a fixed system clock, requiring a data buffering function (latch) to retain digital event
information temporarily, and that input timing is random82. For the non-paralyzable the
dead time is assumed to be non-extended and radiation events occurring during the detector
dead times are not counted83.

1.2.3.3.2

PET data transformation

The PET data provides the number of detected events along each LOR, which can be
identified by both, its projection angle (ϕ), and the distance between the LOR and the center
of the bore (r). Therefore the projection lines are considered to be the integrals of events
distribution over the entire LORs, and in 2D, all projections defined by the Radon
transform p(r, ϕ) and are known as sinogram84. For 3D PET data, reconstruction is usually
completed by reconstructing an individual transaxial slice discretely using the same 2D
reconstruction algorithms. There are two approaches of reconstruction algorithms; the
analytical and the iterative approach. In the analytical approach, the algorithm inverse the
Radon transform on the projection data, while in the iterative approach, the algorithm is
adaptive to the imaging system performance, but requires impractical computing. Clinical
scanners mostly use the iterative-based reconstruction, namely, Ordered Subsets
Expectation Maximization (OSEM) model85, which is a modification of the Maximum
Likelihood Expectation Maximization (MLEM)86. The OSEM algorithm reconstructs PET
images rapidly with less noise.
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1.2.3.4

PET spatial resolution

Current PET systems can achieve spatial resolution in the range of 4-5mm full width half
maximum (FWHM) across the line spread function in the center of the PET FOV87. The
spatial resolution of the PET system depends on the spatial resolution of the detectors
(detector width and depth), distance between the positron emission and the annihilation
positions, and the imperfect collinearity of the two photons. If the detector is thick, the
depth at which the gamma ray interacts with the crystal, cannot be estimated accurately,
which results in an inaccurate estimation of the LOR angle. Consequently, the spatial
resolution is at its highest at the center of the bore, and degrades closer to the bore walls.
Additionally, in a PET system, a collineated pairs of detectors acts as electronic
collimation, which makes PET a more sensitive modality, comparing to other nuclear
medicine modalities69. However, this collimation also causes the PET to have low spatial
resolution. The detection of the annihilation rather than the position of the positron
emission also adds a limitation to spatial resolution for the PET system88. Even with the
current spatial resolution of PET systems, its high sensitivity makes the spatial resolution
acceptable.

1.2.3.5

Photon attenuation

When annihilation occurs, each of the two photons must travel a certain distance through
the material along LOR, known as the path length, before interacting with the detector.
However, each photon travels a distance that is not necessarily equal, and therefore each
photon has a unique distance to travel through the material, and is known as the partial path
length. The partial path length depends on the positions of both the annihilation and the
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detector interacting with photon89. If one or two of the photons interacts with the material
and loses its energy, no coincidence is registered and this is referred to as attenuation of
photons90. Therefore, the probability of both photons being able to penetrate the material
entirely, and reach two detectors in a straight line from each other, is the same as the
probability of true coincidence. The vast majority of interaction between photons and
material for human tissue at 511 keV are in the form of Compton scattering, which, if not
corrected for in the image, will result in overestimation of activity distribution91. Compton
scattering occurs when an emitted 511keV photon interacts with an electron resulting in a
scattered photon with reduced energy and an electron with kinetic energy equal to the
energy lost by the photon in the collision. The extent of energy loss by the photon depends
on the scattering angle. The scattered photon from this interaction loses some of its kinetic
energy and may travel through the medium and interact with another photon92. Compton
scattering is dominant in the energy range 26 keV and 30 MeV for human tissues (low Znumber), and therefore for attenuation correction the Compton scattering must be
accounted for93.

1.2.3.6

Adverse-effect of attenuation on PET image.

Attenuation of photons means loss of energy information which varies along LORs, and
causes higher background noise in the PET image which is called statistical noise. As seen
in figure 1-11-a, attenuated image with no correction, namely, non-attenuation corrected
(NAC) will have depression of activity concentration in the center and intensification of
the image at the edges69,94, while figure 1-11-b is the same image but attenuation corrected
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(AC) where homogeneity, localization of radioactivity and true counts improved in the
overall image.
Figure 1-11 Illustration of axial PET image of a patient a) non-attenuation corrected
(NAC) and b) attenuation corrected (AC).

Reconstruction of PET images without attenuation correction does not address the artifacts,
and consequently prevents the qualitative interpretation of the image by a radiologist will
result in inaccurate quantification of the radioactive concentration in the tissues95,96. In
simple terms, the NAC image cannot be relied on for activity quantification and hence
studying heart functions97.

1.2.3.7
1.2.3.7.1

Attenuation correction of 511 keV
Attenuation coefficient

To overcome the photon attenuation effect, one must determine certain information in the
image reconstruction process. Geometry, material atomic number and position are
important information that can be used to provide a correction factor necessary for the
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attenuation correction process. The attenuation of each material with an atomic number Z
can be estimated from the emitted photons (I0) and detected photons (I) through the
material with thickness (d). This is expressed in a general exponential relation as in eq. (6);

𝐼 = 𝐼0 𝑒 −𝜇𝑑

(6)

where 𝜇 is the linear attenuation coefficient (LAC) of uniform material (Z), measured in
units of cm-1 unit, and is the sum of linear coefficients of each scatter type Compton,
Rayleigh and photoelectric interaction.

For 2D correction, the linear attenuation

coefficients are arranged in a map of attenuation coefficients for a complex geometry and
materials/tissues, known as a µ-map. Thereafter, the µ-map is used for correcting the NAC
PET image from photon attenuation effects, during reconstruction.

The information

required to estimate a µ-map is obtained through an independent process/technique from
the process of diagnostic acquisition, and it is either conducted simultaneously or
sequentially with the imaging acquisition.

1.2.3.7.2

Attenuation correction µ-map

Common techniques used to generate the µ-map for attenuation correction are;
transmission scan-based attenuation map, CT-based attenuation map and the MRI-based
attenuation map. The preferred technique depends on whether the PET system is part of a
hybrid system, or is stand-alone.

1.2.3.7.2.1

Transmission scan-based attenuation map

For stand-alone PET system, the source of information to generate the map is the PET
system itself, and therefore a transmission scan approach is used, where a radioactive
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source (usually

68

Gallium/68Germanium or

127

Cesium) acts as a positrons emitter. The

transmission source is typically fitted between the patient and the detectors of the PET and
rotates a complete circle (360°) around the patient to estimate the attenuation correction
map for both human and hardware present in the PET FOV98-101.

1.2.3.7.2.2

CT-based attenuation map

In the hybrid modalities PET/CT, the CT is used as the source of information to generate
the µ-map for both human and high density materials of the hardware, because the CT
modality possesses a higher spatial and temporal resolution over the PET system, results
in a more spatially accurate attenuation coefficient map30. The µ-map is estimated by
converting the Hounsfield units of the CT measurement into the attenuation coefficient of
the material at 511keV102-105.
It is important to note that, both PET and PET/CT systems can provide the information
needed for µ-map creation, because both human tissues and hardware are visible to the xray and gamma-ray, which are provided by the transmission source or the x-ray tube (CT).
However, in hybrid PET/MRI system, hardware is often invisible, for two reasons: 1- the
MRI system typically provides information only for materials containing 1H nuclei with
relaxation times in the range of those found in the human body; 2- the PET/MRI has no
radioactive source built-in the system to provide information about objects in the FOV.
Therefore, for PET/MRI hardware attenuation correction, CT-based attenuation correction
maps have been primarily used to-date, and they are normally provided by the vendor of
the system. The CT-based µ-map can be achieved by several methods such as; Dual-energy
decomposition82,106-109; scaling110; Segmentation111, or a hybrid between segmentation and
scaling112.
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1.2.3.7.2.3

MRI-based attenuation correction

In PET/MRI, an attenuation coefficient maps are constructed for the human body through
MRI acquisitions with specific pulse sequences113. However, the MRI image provides
information on the tissue proton density rather than electron density. Therefore, the tissues’
attenuation coefficient cannot be directly computed from MRI signal intensity. An example
of this is where the air and compacta bone would show similar intensities on MRI, while
their LAC differ widely. Therefore, the attenuation map of the human body obtained using
MRI provides reliable information on the tissues well distinguished by MRI, such as fat
and water. MRI-based separation of bone and air is still unreliable, which makes it a current
topic of research114-118. The common/basic pulse sequences used for attenuation correction
of the tissue are; 2-point Dixon volume interpolated breath-hold exam (Dixon-VIBE),
homogenization using gradient enhancement (HUGE)119,120, and liver-accelerated volume
acquisition (LAVA)-Flex sequence121. The most advanced pulse sequence recently
developed to address bone is the ultra-short echo time (UTE) imaging sequence122,123,
where the MRI FID signal is sampled less than 200µs after the radiofrequency excitation,
to minimize the signal loss from the bone compartment (air remains MRI-invisible).
Several sequences and techniques for MR-based estimates of human tissue attenuation are
currently under study, but they will not be discussed here, as it is out of the scope of this
thesis. The attenuation correction of the hardware in the PET/MRI system is discussed
separately in section 1.2.3.7.3.

1.2.3.7.2.4

Atlas attenuation correction

This AC techniques depends on pre-established anatomical information with their
coefficients arranged into an atlas map, which can be spatially aligned to MRI data sets.
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Atlas maps depends on selecting atlas that can be applied to wider patient population.
Although the technique does not require generation of the µ-map of the patient during PET
imaging, the atlas approach assumes that attenuation coefficients are adequate in for the
anatomy of all patient population124,125.

1.2.3.7.3

PET/MRI Hardware attenuation correction

Any object present in the PET/MRI FOV during scanning is considered hardware, this
includes; body Tx resonator of the MRI system (figure 1-3), inside the cover of the bore,
headphones, eye tracking system, patient table, all RF receiver arrays (fixed/rigid and
flexible) etc. Attenuation correction for both the inside cover of the bore and Tx body
resonator are addressed by the vendor during reconstruction and few details are reported
on them. On the other hand, mobile hardware such as headphones, can create up to a 13.2%
decrease in activity concentration as determined in phantom studies modeling head
imaging and hence, attenuation correction with CT-based µ-map was proposed126,127.
However, the issue with such mobile hardware (i.e. headphones and flexible arrays) AC,
is that registration of their µ-map to the PET image is often inaccurate. Although the effect
of patient table attenuation is not covered in the literature, it is worth mentioning it here in
this work, since it is the densest hardware in the PET/MRI system. For the patient table, a
CT-based µ-map for attenuation correction is also usually provided by the vendor, for
which, to our knowledge, attempts to improve its attenuation map are rarely reported128.
Beside the patient table, the RF receiver arrays used in cardiac imaging are of concern since
they are considered to be one of the main causes of hardware attenuation, and they are the
subject of ongoing research and development. The effect of receiver arrays on PET
quantification is well covered in the literature, where it was reported to cause subtle
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artifacts and produce quantification errors reaching 28%129-131. The RF receiver arrays can
be grouped into two main groups, “rigid”, which are usually fixed arrays, and “flexible”
which are usually mobile and deformable arrays.

1.2.3.7.3.1

Fixed RF receiver array

Attenuation correction for fixed hardware including RF receiver arrays used in currently
available commercial clinical PET/MRI systems are all performed using CT-based µ-maps.
The registration of the µ-map of fixed and rigid hardware is straight-forward once the
coordinates of the hardware are defined with respect to the PET/MRI coordinate system.
The literature contains some examples of this such as, a fixed breast coil 132, a fixed 31
channel head array133,134 and a dual-tuned head resonator135. Although the registration is
not an issue with fixed arrays, the CT-based µ-map used for attenuation correction is
systematically inaccurate. CT-based hardware attenuation maps tend to suffer from a beam
hardening effect as described earlier (section 1.2.1.2), due to the presence of high-density
and/or high Z-number materials found in housing materials and electronics
components91,136.

1.2.3.7.3.2

Flexible RF receiver array

Flexible arrays might seem light and harmless to PET quantification, yet even the least
number of elements/channels (4 or 6 channels) can cause attenuation of up to 5.1
%129,137,138. In a recent clinical cardiac study on 10 patients, using a flexible six channels
surface RF array, it was reported an error of ~3%, when no attenuation correction was
performed for the array139. In addition to the issue of inaccurate CT-based µ-map, in
general for PET/MRI hardware, accurate registration of the µ-map in the case of flexible
arrays is a great challenge. Several proposed solutions, to correct the photon attenuation
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caused by flexible RF arrays used in cardiovascular PET/MRI imaging, has met with
limited success. The first MR-based attenuation correction approach for flexible RF array
used Cod liver oil capsules as fiducial markers and the UTE sequence for imaging137. This
method addressed the registration rather than the high Z-number of the components
included in the RF receiver array. Another study addressing the registration of µ-map of
flexible RF receiver arrays, incorporated an automatic algorithm to non- rigidly register a
pre-acquired CT-based three-dimensional attenuation template of RF surface arrays to
hardware attenuation maps used for PET AC140. Yet, this algorithm approach required a
considerable amount of computing and resulted in quantification error of counts ranging
from −3.9% to 4.3%. Thereafter, a method to localize and register a CT-based attenuation
µ-map was reported, to correct for the attenuation and scatter of MRI-only, Flexible, 32channel RF arrays used with *MRI141. Although the registration accuracy was sufficient in
that method, quantitative errors were observed when shifting the array attenuation µ-map.
The most recent study to address flexible RF receiver arrays, proposed to use a Microsoft
Kinect V2 depth camera, where the camera determines the array geometry and creates a
dense point cloud. The resulting array geometry is then registered to a pre-acquired CTbased µ-map of the array during the AC process142. This proposed method claimed to
achieve 1% errors in PET quantification, however, the method is limited to: availability of
MR-compatible camera, extra space in the bore, complex and intense computation, all of
which are currently impractical in clinical usage.

* It is of note that 32-ch MRI-only coils are not used routinely by all clinical or research groups based on
availability. Body matrix coils with lower number of channels are often used in lieu of 32-channel cardiac coils.
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1.3

Hybrid PET/MRI imaging modalities

The obvious advantage of hybrid PET/MRI over hybrid PET/CT, is the lower radiation
dose received by the patient. Additionally, while PET/CT suffers from limited contrast soft
tissues, PET/MRI offers a multitude of contrasts amenable to soft tissue imaging such as
diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI as well as MR
spectroscopy capabilities, to only name a few143. PET/MRI is also compatible with dual
modality probes (multinuclear imaging)144. A whole-body PET/MRI system is a powerful
hybrid of the PET and MRI modalities because it provides PET and MRI data sets with
intrinsically perfect temporal and spatial registration. The enhanced soft tissues contrast of
MRI is coupled to the sensitivity and quantitative abilities of PET.

1.3.1

Cardiovascular clinical applications

One of the major advantages of PET/MRI over PET/CT in cardiovascular studies, beside
lowering the exposure to radiation dose, is the possibility of absolute quantification of
myocardial blood flow using N-13 ammonia145, which potentially allows balanced
ischemia in patients with three-vessel-disease to be unmasked. In the mean-time, early
studies also demonstrated the high potential and success of PET/MRI as a diagnostic tool
for myocarditis, and sarcoidosis18,20,146.

Most recently, additional studies demonstrated

that PET/MRI provides the soft tissue contrast that the gold-standard PET/CT cannot,
which is useful in the diagnosis of a number of cardiac diseases21,23,147,148.

The use of

high-density phased array in cardiovascular PET/MRI studies can potentially improve the
correction of respiratory and cardiac motion during the scan, where element sensitivity
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profiles are used to collect information about the cardiac cycle faster than a 12-channels
array149.
Figure 1-12 Comparison between PET/MRI and PET/CT images using FDG
radiotracer for a patient with cardiac sarcoid.

Image is adapted with permission from reference21.

1.3.2

Hybrid PET/MRI challenges

This section focuses only on PET quantification challenges resulting from operating the
PET system hybridized with MRI, rather than as stand-alone PET quantification
challenges.

1.3.2.1

Accurate quantification of PET

Besides motion correction, PET quantification in the MRI environment depends mainly on
how accurate the attenuation correction is, which also depends on the accuracy of both the
attenuation coefficient and the AC-map registration. To achieve this, every source of
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photon attenuation must be defined and its impact must be quantified and hence, solutions
need to be provided to either minimize or eliminate the effect. Sources of attenuation such
as hardware, bone-air segmentation, misregistration between the AC µ-map and PET
image and µ-map truncation (i.e. arms) are all the subject of ongoing research. Both
hardware AC and registration of the AC µ-map to the PET image were described in section
1.2.3.7.3, and therefore, in the next section a brief description of other sources of
attenuation is presented.

1.3.2.1.1

Other sources of attenuation

In addition to the RF receiver arrays’ attenuation as a source of inaccurate quantification,
the presence of foreign objects150 as well as a contrast agent used for image enhancement
can result in quantification errors151.

1.3.2.1.2

Motion

Random motion by the subject, respiratory motion, cardiac motion and blood flow, all are
a source of inaccurate quantification of PET. Motion causes voxels in an image to have
photon counts that do not belong to the same location in the imaged region over time, which
directly affects PET quantification even before AC and AC to PET registration are
performed. There is ongoing research where MRI information (from self navigated
sequences), can address PET motion and correct for their effects152.

1.3.2.1.3

Truncation

This is an issue, since the source of attenuation map of the human, must be derived from
the MRI signal where MRI has limited FOV compared to PET. A recently developed
algorithm that accounts for the truncated arms in the MRI-based µ-map was developed and
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is reasonably acceptable. It is based on a modified maximum likelihood reconstruction of
attenuation and activity (MLAA)153,154. If a non-MRI-based AC µ-map can be developed
for object in the PET FOV, this source of artifact would be eliminated.

1.4

Thesis objectives

This chapter highlighted the need for improving the early diagnostic of cardiovascular
diseases with reliable and fast tools, so that its associated mortality and cost, are reduced.
The methods and tools including imaging modalities of cardiac diseases were briefly
described, with emphasis on hybrid imaging modalities, specifically PET/MRI. Early use
of the hybrid PET/MRI modalities in diagnosing cardiovascular diseases were discussed
where promising results were shown. The advantages of using the hybrid PET/MRI
modality, over other hybrid modalities, was presented in terms of soft tissue contrast and
temporal and spatial resolution. Hardware needed to achieve temporal and spatial
resolution known as RF phased receiver’s array was explained, with their current statuses
of being incapable of achieving desired resolutions, nor allowing accurate PET
quantification. Recent research also has confirmed, that hybrid PET/MRI modality is
urgently needed to attain accurate photon attenuation correction. Consequently, it is clear
that to harness the full potential of the PET/MRI for diagnostics cardiovascular diseases,
two fundamental goals must be reached hence, shaping the objectives of the thesis, and
these are:
1- Achieving high temporal and spatial resolutions by enhancing the MRI modality
part, and
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2- Achieving accurate quantifications of PET activities enhancing the PET modality
part.
While research on motion corrections, truncation and attenuation correction of human body
are on-going, to minimize errors in PET quantification, this thesis is focused on the
hardware contribution to the quantification error in PET.
Although there are arrays capable of providing excellent resolutions for the MRI-only
modality, yet, they are unfit for the PET environment due to the unacceptable errors they
cause in quantification of PET activity. Therefore, new prospectively-designed RF arrays
for the hybrid PET/MRI are needed. Additionally, new approaches to produce accurate
attenuation correction are also required, through accurate µ-maps and registration. With
this in mind, the following research questions have been identified:
1- Can high-density 32 channels RF array prospectively-designed for cardiovascular
PET/MRI provide adequate MRI and PET performance?
2- Can the prospectively-designed multi receivers’ RF array achieve acceleration
factor of R > 2 (temporal resolution) with better SNR (spatial resolution) than
currently used in the PET/MRI array?
3- Can the prospectively-designed 32 channels RF array provide patient comfort and
swift workflow?
4- Can the anterior part of the 32 channels RF phased array attenuate photons less than
the current PET/MRI phased array (3%)?
5- Can the receivers’ RF phased array, fully or partially, operate without attenuation
correction µ-map and hence be free of errors caused by misregistration?
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6- If the prospectively-designed phased array still requires µ-map to correct the
attenuation, can a new approach of attenuation correction be developed and avoid
the beam hardening artifacts, currently existing when using the CT modality?
7- Does the newly developed approach improve the PET quantification?
8- Can the novel approach to generate attenuation correction µ-map be applied to other
hardware such as patient table used in the PET/MRI system for better PET
quantification?
Questions 1 and 2 are addressed in chapter 2, while questions 3 to 5 are addressed in
chapter 3, and questions 6, 7 and 8 are addressed in chapter 4.

The research questions have been addressed in this thesis by focussing them down to three
objectives:
1- To assess MRI performance of a novel prospectively-designed 32 channels RF
phased array for hybrid PET/MRI cardiovascular imaging, and to compare this to
currently used phased arrays.
2- To evaluate the photon attenuation at 511keV caused in the novel prospectivelydesigned 32 channels RF phased array for hybrid PET/MRI cardiovascular imaging
and to compare currently used phased arrays with and without µ-maps.
3- To develop a novel method to generate attenuation correction maps of hardware,
used in hybrid PET/MRI modalities, without the need of CT and to assess its
accuracy.
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Chapter 2
2

Assessment of a Novel 32-Channel Phased Array for

Cardiovascular Hybrid PET/MRI Imaging: MRI performance

2.1

Introduction

Hybrid imaging systems combining positron emission tomography (PET) and magnetic
resonance imaging (MRI), namely PET/MRI scanners, are unique in providing both
functional and intrinsically-registered anatomical information from both PET and MRI
simultaneously. PET/MRI systems are therefore highly advantageous for multimodality
studies, which can improve the characterization and grading of metabolically active tumors
using 18F-fluoro-deoxy-glucose (FDG)1,2, while superimposing such activity on anatomical
images with the superior soft-tissue contrast of MRI to identify active inflammation3. In
addition, by combining perfusion tracers such as 13N-labeled-Ammonia (13NH3) with FDG,
the PET/MRI has also been shown to be successful in cardiovascular imaging where
left/right ventricular function and myocardial perfusion and blood flow in surrounding
vessels of the heart can be quantified4-6.
Since the emergence of whole-body PET/MRI systems, several technical challenges have
been identified and commonly reported around the accurate quantification of the 511 keV
annihilation photons detected in PET images7-9. The greatest challenge, apart from
respiratory and cardiac motion, is the accurate correction of PET counts due to attenuation
within materials located between the radioactive source and the PET detectors. Attenuation

62

of 511 keV photons is caused by the presence of the patient body (tissues, air cavities,
blood and bones) and the scanner hardware in the PET field-of-view (FOV). Hardware,
such as the patient bed, audio communication system and radio frequency (RF) resonators
have the most attenuating effect and cause scattering or simply block the gamma rays from
reaching the PET detectors10-12.

However, RF phased arrays are crucial for MRI parallel

imaging as they achieve the shortest scan time with the highest spatial and temporal
resolutions, and their use, particularly for cardiovascular MRI, is an essential part of the
standard of care. The advantage of parallel imaging with high acceleration factor up to 4
in one-dimension for cardiac MRI was proven to be beneficial for imaging13. Therefore, a
phased array with 32-channels is highly desired. Although a few dedicated PET/MRI RF
phased arrays have been developed for brain14-16 and breast17 imaging, no phased array, to
our knowledge, has been developed for PET/MRI cardiovascular imaging. Currently, MRIonly research systems offer phased arrays with up to 128-channels for cardiovascular
imaging18, while clinical PET/MRI

systems offer up to 12-channels. Although

commercially available, PET/MRI arrays are typically restricted to a lower number of
channels to reduce attenuation of gamma rays. Nevertheless, PET/MRI arrays have been
reported to cause variation of the standardised uptake value (SUV) ranging from 18% to
60% closer to the array, if the attenuation correction (AC) is not included during the PET
image reconstruction19-21.
Meanwhile, developing a dedicated PET/MRI phased array with a higher number of
channels is technically challenging, leading researchers to focus on the approach of
correcting the attenuation of the currently available MRI arrays12,22-24. The common
approach to correct for attenuation of an RF phased array is to generate a hardware AC
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map, also known as a µ-map, produced from a CT scan at a specific tube voltage25,26. The
process of generating a hardware-AC map is normally conducted by the scanner
manufacturers for all vendor-provided hardware, prior to delivery of the scanner. AC maps
are accurately included during PET image reconstruction for fixed rigid hardware, such as
the patient table and rigid RF arrays. For more accurate AC of flexible RF arrays, fiducial
markers can be added to guide the registration of the hardware AC map with the PET image
12

.

Although, RF arrays with a lower number of channels are adequate for most oncologic
applications, simultaneous PET/MRI for cardiovascular imaging can still benefit from
faster parallel-imaging using a dedicated PET/MRI RF 32-channel phased array
prospectively designed for minimal PET attenuation. It is, therefore, important to
investigate alternative approaches to minimize the attenuation caused by a high-density
phased array for cardiovascular PET/MRI imaging. In this work we evaluate the thirdparty dedicated 32-channel phased array (developed by a local company) optimised for
parallel imaging of the heart with PET/MRI. The quality parameters for parallel imaging,
such as the geometry factor (g-factor), SNR and noise correlation coefficients, are
compared to the two commercially available and currently used, MRI-only 32-channel and
the PET/MRI 12-channel arrays.
The reduction in PET signal due to attenuation caused by the candidate array was briefly
examined and reported. Although this work focusses on the MRI performance of the array,
the equally important PET performance of the candidate array will be compared in detail
to the existing arrays and will be reported in a separate manuscript. Only a cursory
evaluation of PET performance will be reported herein. We hypothesize that if the MRI
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quality parameters of the PET/MRI 32-channel array are similar with those produced by
MRI-only 32-channel array, and if global gamma ray attenuation of the PET/MRI 32channel array is less than that of the mMR 12-channel array, the MRI performance of the
PET/MRI 32-channel array would be acceptable for hybrid/simultaneous PET/MRI
cardiovascular imaging.

2.2
2.2.1

Methods and Materials
Description of the arrays

The PET/MRI phased array consists of two parts; a posterior and an anterior, allowing the
patient to be scanned in head-first, supine position. The RF elements were arranged to
cover the entire heart region and can be connected to the scanner at four ports. The ports
are arranged, with two ports for the anterior array, and two ports for the posterior array,
allowing each part of the array to be used independently. The anterior and posterior part of
the 32-channel arrays have sixteen elements each, arranged in a 4x4 fashion to maximize
acceleration factor in directions within the coronal plane. The flexible body mMR 6channel array (Siemens Healthcare Limited, Erlangen, Germany) elements are arranged in
3x2 fashion, which is similar in arrangement to the spine matrix array (Siemens Healthcare
Limited, Erlangen, Germany). Therefore, the flexible body mMR 6-channel array was
combined with six elements from the posterior spine matrix mMR array formulating a set
of mMR 12-channel array used in this work.
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In this study, a commercially available cardiac MRI-only 32-channel array (In-Vivo
Corporation, Gainesville, FL, USA) was used, while the prototype novel PET/MRI 32channel was provided for assessment by a local company (Ceresensa. Inc, Canada 2016).

Figure 2-1 Phantom experiment setup for the three arrays during MRI
measurements.
PET/MRI 32-ch

MRI-only 32-ch

mMR 12-ch

The experiment setup for the three arrays PET/MRI 32-channel, MRI-only 32channel, and mMR 12-channel. Position of isocenter were kept unchanged from one
acquisition to the other.

2.2.2

MRI Phantom imaging

For this study, a balanced steady-state free precession (balanced-SSFP or TrueFISP in
vendor’s nomenclature) pulse technique was selected due to its ability to acquire subsecond scan time per slice and its sensitivity to high fluid-tissue contrast

27

. All MRI

acquisitions were performed on a 3.0T PET/MRI system (Biograph mMR Software
Version VE11P, Siemens Healthineers, Erlangen, Germany).
All three arrays operated with posterior and anterior parts, making the condition of the
measurements identical as seen in Figure 1. Phantom imaging data were acquired using a
standard cylindrical acrylic container (OD = 28cm) filled with a solution of both
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NiSO4·6(H2O) and NaCl in distilled water. To mimic the location of the heart in a patient,
the distance between the anterior and posterior array elements were kept to approximately
27cm and the 12cm high cylindrical phantom was centred between them, leaving the
elements approximately 7.5cm away from the surface of the phantom. To examine the
parallel imaging capabilities of each array, a single 2D-slice at the center of the phantom
in the coronal plane was acquired using the manufacturer’s 2D TrueFISP sequence.
Multiple acquisitions were performed with phase encoding in left-right (LR) direction, for
different acceleration factors ranging from R=1 to R=6. A second set of acquisitions similar
to the above was performed, changing the phase encoding into the foot-head (FH) direction,
for the same number of acceleration factors.

The image reconstruction utilised the

generalized autocalibration partially parallel acquisitions (GRAPPA) technique 28, with 64
reference lines for all accelerations. The 2D TrueFISP-GRAPPA parameters for the LR
and FH encoding were: BW = 440 Hz/pixel, FOV = 253 x 253mm, spatial resolution of
1.3 x 1.3 x 8.0 mm3, flip angle = 50°, and TE/TR = 2.40/4.79ms. For each acceleration
factor R, noise data was also acquired with the same parameters except the RF amplitude
was set to zero. The above two sets of coronal acquisitions were repeated two times on the
phantom for each array, with a total of 64 acquisitions for each array.
A reflected power test was performed to ensure that there is no undue change to the RF
field transmitted by the integrated body resonator due to poor decoupling from the receiver
array 18. A low percent difference in reference voltage between the “with-array” and “noarray” conditions indicates that no undue amount of transmitted energy is absorbed within
the receiver array. The reference voltage was determined by the scanner’s automated RF
calibration procedure and represents the voltage necessary to obtain a 180o flip angle using
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a 1ms square RF pulse. This test was performed only on the PET/MRI 32-channel array,
since it is not licensed or approved by a third-body regulator.

2.2.3

In-Vivo Imaging

For in-vivo imaging, acquisitions were performed on three healthy volunteers, recruited
with written informed consent according to a research ethics protocol approved by the
Research Ethics Board (protocol ID 6319). In addition to the same pulse sequences that
were performed in the phantom acquisitions, ECG-triggered 2D TrueFISP cine images
were acquired on a single breath-hold with axial double-oblique orientation and a 4chamber view of the heart. The imaging parameters of the cine MRI with activated
GRAPPA for R = 2 (anterior-posterior phase encoding) were: TE/TR = 1.58/36.3 ms; 25
segments; spatial resolution of 1.0 x 1.4 x 6.0 mm3; FOV = 253 x 300mm; flip angle = 50°;
and BW = 930±16 Hz/pixel. For the three volunteers the average beat-to-beat interval was
906±50ms. Each volunteer was fitted with MRI-compatible ECG electrodes, so that the
data is retrospectively ECG-gated. Volunteers were imaged in the head-first supine
position, with a total acquisition time of under 10 seconds in 13 heart beats. Each volunteer
was imaged consecutively with all three arrays under the same conditions and using the
same imaging parameters as described above. The full duration of an imaging session for
one volunteer with the three arrays was under 60 minutes.

2.2.4

Data processing and analysis

For phased arrays, SNR is more likely to be overestimated if measured from the magnitude
of the image, due to bias of the Rician-distributed noise in the magnitude image 29,30. The
noise measured by a phased array is influenced by the overlapping of each element and
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cannot be treated as a single source of noise, i.e. a fraction of the noise observed by each
element is correlated noise and must be accounted for via noise correlation coefficient to
avoid overestimation.

Notably, the mMR 12-channel array utilises OEM-specified

combiner chip, while both MRI-only and PET/MRI arrays do not. Therefore, using raw
data (k-space) for signal and noise was necessary to perform appropriate and fair
comparison and identical reconstruction. Two techniques were introduced30,31, by which
SNR of phased arrays can be estimated in a pixel-by-pixel fashion. Both techniques have
addressed the geometric overlapping of array elements (known as g-factor). In this work,
the g-factor was computed from both the estimated noise covariance, which was computed
from noise correlation coefficients of the array elements in Appendix A (Pruessmann et al.,
1999), and sensitivity map (spatial element sensitivity) which was estimated off-line. The
formulas used to compute sensitivity, g-factor and SNR parameters are described by
equations [1], [2] and [3] in30, and presented here for convenience.

𝑺𝒑𝒋 = 𝑺𝒋 ∗ 𝒓𝒑

[1]

𝐠𝒑 = √((𝑺𝑯 𝜳−𝟏 𝑺)−𝟏 )𝒑,𝒑 (𝑺𝑯 𝜳−𝟏 𝑺)𝒑,𝒑

𝑺𝑵𝑹𝐠 =

𝑺𝑵𝑹𝟎
𝐠 𝒑 √𝑹
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[3]

[2]

Where S is the complex sensitivity matrix,

𝚿 the noise correlation coefficient, r is the

aliased p pixel position and j is the array element number. The g-factor-based SNRg was
estimated on a pixel-by-pixel fashion for multiple acceleration factors R=2 to R=6 from
the fully sampled image SNR0, which was found by the difference method32.
For the two phantom experiments, global mean, from masked images, and standard
deviation (SD) of the SNR0, SNRg, and, g-factor were calculated at each R value
independently for both 1-dimension (phase encoding LR or FH) and 2-dimensions (phase
encoding is in both LR and FH). The relationship between mean SNRg and inverse g-factor
as functions of R were examined and compared for the three arrays. Mean and SD of the
noise correlation coefficients were estimated excluding the self-correlated coefficients
(diagonal values of the matrix). The percentage difference of the quality parameters for the
MRI-only and PET/MRI 32-channel arrays were estimated using equation [4], where v1 is
the PET/MRI array parameter value and v2 is the MRI-only array parameter value. For the
interpretation of the percentage difference, a criterion was established in which the absolute
function in the formula was ignored allowing directional estimates. Instead, the measured
parameters for the MRI-only array were subtracted from those of the PET/MRI array.
Hence, a negative percentage difference would indicate a better performance of the
PET/MRI array for the g-factor parameter. All quality parameters of the parallel imaging
and data analysis for each array were computed using Matlab 9.3.0 (The MathWorks,
Natick, MA, USA).

% 𝒅𝒊𝒇𝒇𝒆𝒓𝒆𝒏𝒄𝒆 =

𝒗𝟏 −𝒗𝟐
𝟎.𝟓 (𝒗𝟏 +𝒗𝟐 )
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100%

[4]

2.2.5

PET activity test

To estimate PET photon attenuation, 2-point Dixon acquisitions were performed prior to
the PET acquisition, with and without the array, on the mMR Ge-68 Daily Quality Control
(QC) phantom (Siemens, Healthineers, Erlangen, Germany). The Dixon acquisition
consisted of a 3D dual-echo spoiled gradient sequence with the following parameters:
TE/TR = 1.23/3.96 ms; slice thickness = 3.1mm; flip angle = 9° and FOV = 312 x 500 mm.
The phantom was mounted following the procedure used in the daily QC, where neither
the patient table nor array were present in the bore of the PET/MRI system during the
Dixon acquisition. An 8 mins PET acquisition was carried out immediately after the Dixon
while the array was placed around the phantom. Placing the array took no more than 2 min,
therefore, only the last 6 mins of the data were used for PET image reconstruction. The
resultant data was labelled as “no-array, no-table” and was used as a base line to compare
to PET/MRI array. The same acquisitions were repeated on the phantom but with the
array’s anterior part placed on the top of the QC phantom, while the array’s posterior part
was placed below the QC phantom. Mean of PET counts per seconds (CPS) from the
acquisitions, without applying AC maps, were estimated from the central transaxial slice
of the phantom for each PET acquisition.

2.3

Results

The voltage recorded for 180° RF pulse with the volunteer in the scanner, but without the
PET/MRI 32-channel array, was 562 V. It was 598 V with the volunteer loading the array
in the scanner, resulting in only 6% difference. This percentage difference of the reference
voltages is indicative of the decoupling inefficiency of the array and shows that the
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coupling between the array and the body resonator is minimal. In this case, the PET/MRI
32-channel array shows 94% decoupling efficiency.

2.3.1

MRI phantom imaging

Table 2-1 summarizes the MRI quality parameter means and SDs, such as SNR 0, SNRg
sensitivity-based g-factor and inverse g-factor as estimated for all arrays at all acceleration
factors, in 1D (LR or FH) and 2D. The table also includes the mean and SD of the noise
correlation coefficients for all arrays. Noise correlation coefficient matrices representing
between-channel coupling for the three arrays are graphically represented in Figure2- 2.
Each array produced a mean noise correlation coefficient of less than 0.2 (20% correlation).
For example, noise correlation means at R=2, excluding self-correlated elements
(diagonal), were 10%, 11% and 15% for the MRI-only 32-channel, PET/MRI 32-channel
and mMR 12-channel arrays, respectively.
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Table 2-1: Estimated mean ± SD values of the parallel imaging quality parameters.
PET/MRI 32-channel

MRI-only 32-channel

mMR 12-channel

R=1

R=2

R=3

R=4

R=6

R=1

R=2

R=3

R=4

R=6

R=1

R=2

R=3

R=4

R=6

0.110
±0.004

0.110
±0.002

0.120
±0.011

0.120
±0.004

0.120
±0.003

0.090
±0.003

0.100
±0.004

0.100
±0.001

0.110
±0.001

0.110
±0.002

0.150
±0.001

0.150
±0.021

0.150
±0.011

0.150
±0.001

0.160
±0.001

SNR0

965±112

-

-

-

-

871±98

-

-

-

-

749±90

-

-

-

-

SNRg

-

608±57

428±38

271±25

88±22

-

581±71

386±66

229±34

55±18

-

488±58

247±26

99±7

24±3

g-factor

1

1.06±0.05 1.25±0.16 1.81±0.54 7.03±4.59

1

1.06±0.05 1.32±0.18 2.13±0.79 15.41±13.56

1

1.05±0.04 2.10±1.07 6.94±5.42 41.75±39.56

1/g-factor

1

0.98±0.04 0.82±0.10 0.60±0.16 0.23±0.15

1

0.95±0.04 0.77±0.10 0.53±0.17 0.16±0.15

1

0.96±0.04 0.59±0.25 0.28±0.24 0.08±0.13

noise
correlation
coefficient
Encoding
1D-LR

1D-FH
SNR0

929 ±107

-

-

-

-

816±96

-

-

-

-

655±83

-

-

-

-

SNRg

-

648±53

467±35

279±26

73±19

-

549±41

365±59

216±18

52±12

-

443±56

224±23

90±6

21±2

g-factor

1

1.01±0.02 1.16±0.11 1.82±0.59 8.97±6.27

1

1.06±0.05 1.32±0.17 2.12±0.79 15.44±13.54

1

1.05±0.04 2.10±1.06 6.93±5.40 43.77±41.75

1/g-factor

1

0.99±0.02 0.87±0.08 0.60±0.17 0.19±0.16

1

0.95±0.04 0.77±0.10 0.53±0.17 0.16±0.15

1

0.96±0.04 0.59±0.25 0.27±0.24 0.08±0.13

2D

R=2x2

R=2x3

R=2x4

R=3x3

R=3x4

R=2x2

R=2x3

R=2x4

R=3x3

R=3x4

R=2x2

R=2x3

R=2x4

R=3x3

R=3x4

SNRg

572±23

404±21

237±16

324±19

192±14

623±26

406±19

233±15

330±16

198±13

427±21

196±15

64±14

132±16

42±9

g-factor

1.05±0.03 1.23±0.14 1.97±0.66 1.59±0.36 2.52±0.94 1.06±0.03 1.35±0.18 2.28±0.88 1.72±0.42 2.73±1.14 1.12±0.06 2.75±1.89 10.16±5.84 5.41±4.86 18.51±13.03

1/g-factor

0.95±0.03 0.82±0.09 0.56±0.16 0.66±0.13 0.45±0.15 0.94±0.03 0.75±0.10 0.50±0.16 0.61±0.13 0.42±0.14 0.89±0.05 0.50±0.24 0.19±0.22 0.34±0.21 0.13±0.16

The parallel imaging quality parameters SNRg, g-factor and noise correlation coefficients, are estimated for different phase encoding
direction in 1D (LR or FH) and in 2D (LR & FH).

Figure 2-2: Noise correlation coefficients matrix for each of the three arrays.

PET/MRI 32-ch

MRI-only 32-ch

mMR 12-ch

Correlation matrix for the three arrays; PET/MRI 32-channel, MRI-only 32-channel,
and mMR 12-channel. The scale of the color bar represents the correlation
coefficients values, which could also be reported as correlation percentage. The
average noise correlation coefficients (excluding the matrix diagonal) for the
PET/MRI array was measured to be < 0.13 (< 13% correlation).

Figure 2-3: Mean and SD of the noise correlation coefficients shown as a function of
acceleration factor for the three arrays.

Of note: the mMR 12-channel array mean noise correlation shows a drop at R = 2,
with SD of 0.021 (2.1%). The MRI-only 32-channel shows the lowest values, yet noise
correlation coefficients increases by 0.019 (1.9%) from R = 1 to R = 6, while the
PET/MRI 32-channel array has shown an increase by 0.012 (1.2%).

Figure 2-3 displays means and SDs of the noise correlation coefficients for the three arrays
as a function of the acceleration factor, with the mMR 12-channel array producing the
largest standard deviation (2.1%) of all three arrays.
Figure 2-4 presents measured inverse g-factors maps for 1D acceleration (phase encoding
in LR and FH direction) for all arrays. The 1/g-factor maps of the PET/MRI 32-channel
array are compared to the two commercial arrays for each acceleration factor and produced
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the lowest mean g-factor and, hence, the lowest noise amplification of the three arrays, as
recorded in Table 2-1. For example, at acceleration factor R=3 in the LR direction, the
mMR array produced a mean g-factor of 2.10 compared to 1.32 for the MRI-only 32channel array and 1.25 for the PET/MRI 32-channel array. A similar pattern of g-factor
was also observed when estimated with encoding in the FH direction.
Using percentage difference formula number [4] with parameters in Table 2-1, one can
compare any parameters of one array to another. Beyond acceleration factor of R=2 in
either encoding directions, the PET/MRI 32-channel array shows more than 30%
improvement in g-factor and SNRg compared to the mMR array. The PET/MRI 32-channel
array mean g-factor for R=3 in the FH encoding direction was improved relative to the LR
phase encoding direction by 7%, while the MRI-only 32-channel array showed no changes
in mean g-factors at R=3 according to phase encoding direction.
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Figure 2-4: 1/g factor maps for the three arrays with R=2 to R=6 in both LR and FH
phase encoding direction.

Notice in the figure, a substantial noise amplification beyond R=2 for the mMR 12channel array in comparison to the two 32-channel arrays.
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Figure 2-5: 1/g factor maps in the case of 2D acceleration with RR = 2x2 to RR=3x4.

The PET/MRI 32-channel array achieves the least noise amplification with max of
0.97 at RR=3x3 in comparison to 0.88 for the MRI-only array, while the mMR 12channel array produced.

Table 2-2: Percent difference of parallel imaging quality parameters comparing
both 32-channel arrays.

PET/MRI 32-ch and MR-only 32-ch Percentage Difference (%)
R=1 R=2 R=3
R=4 R=6
SNR0
10.3 19.2 11.7
-1.1
-0.2
SNRg
5.2
4.4 10.4
16.9
45.6
Noise Correlation coefficients
18.4 11.6 11.2
10.2
10.7
Max g-factor
0
6.0 -5.1 -16.4* -107.0*
Mean g-factor
0
0.5 -5.5 -15.9* -74.7*
Mean 1/g-factor
0
-0.3 5.9
11.9
39.3
*Negative value indicates advantage of the PET/MRI 32ch over the MRI-only.
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Figure 2-5 presents the 1/g-factor maps for selected 2D acceleration factors RLR x RFH =
2x2, 2x3, 2x4, 3x3 and 3x4. In Figure 2-5 and Table 2-1, the 2D acceleration is shown to
be possible with the PET/MRI 32-channel for up to 3x3 with only a SNR loss of less than
half of that of the mMR 12-channel array, and 8% better than the MRI-only 32-channel
array.

Table 2-2 focuses on the percentage differences of the parallel imaging quality

parameters between the two 32-channel arrays for the case of L-R encoding direction. The
percentage difference between the non-accelerated (R=1) SNR0 for both arrays was 10.3%,
while the SNR0 measured from the PET/MRI array at R=2 was better than the MRI-only
array by approximately 19%. The percentage differences in the case of mean g-factor for
R=1 and R=2 were found to be negligible, while for accelerations factors R >2, the mean
g-factor of the PET/MRI array was more than 5% over that measured from the MRI-only
array, as seen in Table 2-2. The mean and SD of SNRg, as a function of acceleration factor
for the three arrays are displayed in Figure 2-6.

2.3.2

MRI in-vivo imaging

The SNRg pixel-by-pixel maps from in-vivo acquisitions (single centre-slice 2D TrueFISP,
cine disabled), at 1D acceleration factor R=3 and R=4, were derived by utilising elements
sensitivity and are presented in Figure 2-7. At the mid-ventricular level and up to the apex,
the effect of the noise amplifications at R=3 (and higher) are comparable for the 32-channel
arrays and they outperform the mMR 12-channel array. A higher SNRg from the in-vivo
acquisitions (2D TrueFISP cine 4-chamber view) on a male volunteer was achieved using
the PET/MRI 32-channel array (Figure 2-8). The line profile of the SNRg across the center
of a 4-chamber view of the heart was approximately 15% higher for the PET/MRI 32channel array over the two other conventional arrays (Figure 2-9).
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Figure 2-6: Estimated SNRg as a function of acceleration rates from R=1 to R=6
with GRAPPA reconstruction.

The estimated SNRg shown here follows the theory and is in agreement with
expected profile as first proposed by (Griswold et al., 2002)
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Figure 2-7: Comparison of In-vivo SNRg maps generated using the three arrays at
R=3 and R=4.

PET/MRI 32-ch

MRI-only 32-ch

mMR 12-ch

In-vivo maps of SNRg (i.e. including noise amplification considerations) comparison
of the three arrays, using a single centre-slice 2D TrueFISP image acquired at R=3
and R=4, with left-right encoding. The SNR maps show greater degradation of the
SNR for the mMR 12- channel compared to the 32- channel arrays at higher
acceleration factors.
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Figure 2-8: 4-chamber view images acquired with a 2D TrueFISP cine sequence on
a male volunteer.
PET/MRI 32-ch

MRI-only 32-ch

mMR 12-ch

The first of 25 4-chamber view images acquired with a 2D-TrueFISP cine sequence
on a male volunteer with acceleration factor of 2 (R=2).
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Figure 2-9: A centre line profile of the SNRg map of the heart for the three arrays.

The centre line (dashed line in Fig.2-8) profile of the heart showing SNRg generated
by the three arrays using a 2D TrueFISP cine 4-chamber view. The scanning
plane/orientation are not identical, and the line had to be centred in the heart as much
as possible for each acquisition above.

2.3.3

PET imaging

Figure 2-10 compares center-slice of the PET activities acquired on the Ge-68 phantom for
the three arrays and the “no-array, no-table” measurement. The estimated global mean of
the PET counts per second (CPS), from the circled region contouring the phantom, were
found to be: 557CPS, 534CPS, 436CPS and 395CPS, for “no-table no-array”, PET/MRI
32-channel array, MRI-only 32-channel array and mMR 12-channel array respectively.
The difference between the PET CPS from “no-table, no-array” to PET/MRI 32-channel
array was 4.1%.
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Figure 2-10: PET counts per second (CPS) map of the middle slice of the Ge-68
phantom for each array separately and reference (“no-array, no-table”).

The global mean count per seconds were measured from the region contoured by the
red circle. The figure is windowed to accentuate the hardware attenuation artefacts
visible immediately outside the phantom. All images used identical windowing.

2.4

Discussion and Conclusion

Overall, the MRI performance assessed by the percentage differences of noise correlation,
g-factor and SNR between the two 32-channel arrays is found to be similar and favoured
the PET/MRI array greatly at acceleration of R=4 and R=6. The design of this dedicated
PET/MRI array has provided superior (>30%) in all the results over the mMR 12-channel
array for acceleration factors greater than 2, theoretically allowing for use of shorter breathholds, which is often critical in cardiac imaging.
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The method used in this work to assess the MRI quality parameters for parallel imaging
are commonly used by researchers as reported in 13,18,33-35. This work has combined the use
of both parallel imaging techniques with high density arrays to shorten the breath-hold
during acquisition which is necessary for cardiovascular imaging. At R=4 using TrueFISP
imaging, the shortest breath-hold that could be achieved was approximately 9 seconds
producing 25 images of a single slice.
Unlike the two currently-used arrays, the anterior portion of the PET/MRI array is very
light and thin and as such does not conform to the subject’s chest under its own weight.
This was resolved by using straps to achieve adequate conformity and proximity to the
subject’s body. With this design, its elements have the highest proximity to the heart of the
three arrays, which benefits penetration depth and results into a better SNR far from the
array as demonstrated by Figure 2-9.
We recorded lower noise correlation SDs (0.5%) for both 32-channel arrays compared to
the mMR 12-channel array, as seen in Figure 3, which indicates greater stability of the
arrays’ noise correlation coefficients as a function of acceleration factor during parallel
imaging. One element of the PET/MRI 32-channel array produced a noise coefficient of
61% and this may have caused the high mean of the coefficients. This could be due to offresonance tuning of the element which introduced excess noise to the neighbouring ones.
We have demonstrated with the phantom results in Figures 2-4 and 2-5 that the 32-channel
PET/MRI array produces higher SNR than the other two arrays for 1D and 2D acceleration,
which confirms the array is a strong candidate for use as the MRI receiver array in hybrid
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PET/MRI cardiovascular imaging. As seen in Table 2-1, at almost all R values, the mean
g-factor of the PET/MRI 32-channel array showed better results than those of the other two
arrays. The SNR behaviour from phantom and in vivo measurements matches those
reported in 28 regarding parallel imaging theories compared to the effect of acceleration on
SNR measured with phased arrays. It was noticed that the estimated SNRg of the MRI-only
32-channel array at R=4 is 17% less than the PET/MRI array, yet it produced the smallest
noise correlation coefficient. The reason for this behaviour could be due to smaller element
size and geometry differences from one array to the other, or, alternative reasons may be a
suboptimal output gain adjustment or imperfect signal pre-amplification. The parallel
imaging quality parameters of the prospectively designed PET/MRI 32-channel array are
comparable to the MRI-only array confirming its ability to be employed for 1D acceleration
up to R=6, and 2D parallel imaging up to acceleration of 3x3.
In conclusion, the PET/MRI 32-channel array prospectively-designed for simultaneous
PET and MRI demonstrated competitive MRI performance compared to both the 32channel MRI-only array and the 12-channel PET/MRI array. PET photon attenuation
caused by the PET/MRI 32-channel array was measured to be <5% compared to the noarray PET photon activities. The PET performance will be studied in detail and will be
presented in a separate manuscript.
We therefore conclude, that the PET/MRI 32-channel array studied here, is a viable
alternative for simultaneous cardiovascular PET/MRI using parallel imaging.

The

PET/MRI array can surpass currently used arrays, particularly for high parallel imaging
acceleration applications.

86

2.5

Acknowledgements

The authors gratefully acknowledge: Funding from MITACS (Application Ref. IT12869)
(to JThé), an industry-sponsored internship (to AF) in collaboration with Multi Magnetics
Inc (London, Ontario, Canada). Partial salary support of AF by NSERC Discovery Grant
(No. RGPIN-2016-05055) (to JThé), infrastructure support by Ontario Research Fund
(RE07-021) (to FSP) and by Canada Foundation for Innovation Grant (11358) (to FSP).

87

2.6

References

1.

Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS. Positron Emission
Tomography/Magnetic

Resonance

Imaging:

The

Next

Generation

of

Multimodality Imaging? Semin Nucl Med. 2008;38(3):199-208.

2.

Catana C, Drzezga A Fau - Heiss W-D, Heiss Wd Fau - Rosen BR, Rosen BR.
PET/MRI

for

neurologic

applications.

Journal

of

Nuclear

Medicine.

2012;53(1916–1925).

3.

White JA, Rajchl M, Butler J, Thompson RT, Prato FS, Wisenberg G. Active
Cardiac Sarcoidosis First Clinical Experience of Simultaneous Positron Emission
Tomography– Magnetic Resonance Imaging for the Diagnosis of Cardiac Disease.
Circulation. 2013;127(22):e639-e641.

4.

Camici PG, Prasad SK, Rimoldi OE. Stunning, Hibernation, and Assessment of
Myocardial Viability. Circulation. 2008;117(1):103-114.

5.

Nensa F, Beiderwellen K, Heusch P, Wetter A. Clinical applications of PET/MRI:
current status and future perspectives. Diagnostic and Interventional Radiology.
2014;20(5):438-447.

6.

Nensa F, Bamberg F, Rischpler C, et al. Hybrid cardiac imaging using PET/MRI:
a joint position statement by the European Society of Cardiovascular Radiology
(ESCR) and the European Association of Nuclear Medicine (EANM). European
Journal of Hybrid Imaging. 2018;2(1):14.

7.

Pichler B, Judenhofer M, Wehrl H. PET/MRI hybrid imaging: devices and initial
results. Eur Radiol. 2008;18(6):1077-1086.

88

8.

Wagenknecht G, Kaiser H-J, Mottaghy FM, Herzog H. MRI for attenuation
correction in PET: methods and challenges. Magnetic Resonance Materials in
Physics, Biology and Medicine. 2013;26(1):99-113.

9.

Rausch I, Quick HH, Cal-Gonzalez J, Sattler B, Boellaard R, Beyer T. Technical
and instrumentational foundations of PET/MRI. European Journal of Radiolog.
2017;94:A3–A13.

10.

Tellmann L, Quick H, Bockisch A, Herzog H, Beyer T. The effect of MR surface
coils on PET quantification in whole-body PET/MR: results from a pseudoPET/MR phantom study. Medical physics. 2011;38(5):2795-2805.

11.

MacDonald LR, Kohlmyer S, Liu C, Lewellen TK, Kinahan PE. Effects of MR
surface coils on PET quantification. Medical physics. 2011;38(6):2948-2956.

12.

Kartmann R, Paulus DH, Braun H, et al. Integrated PET/MR imaging: Automatic
attenuation correction of flexible RF coils. Medical physics. 2013;40(8):082301.

13.

Wintersperger BJ, Reeder SB, Nikolaou K, et al. Cardiac CINE MR imaging with
a 32-channel cardiac coil and parallel imaging: Impact of acceleration factors on
image quality and volumetric accuracy. J Magn Reson Imaging. 2006;23(2):222227.

14.

Anazodo UC, Thiessen JD, Ssali T, et al. Feasibility of simultaneous whole-brain
imaging on an integrated PET-MRI system using an enhanced 2-point Dixon
attenuation correction method. Frontiers in Neuroscience. 2015;8(434).

15.

Sander CY, Keil B, Chonde DB, Rosen BR, Catana C, Wald LL. A 31-channel MR
brain array coil compatible with positron emission tomography. Magn Reson Med.
2014;73(6):2363-2375.

89

16.

Anazodo UC, Farag A, Theberge J, et al. Assessment of PET performance of a 32Channel MR Brain Array Head Coil Compatible with PET for Integrated PETMRI. Paper presented at: PSMR; May 23rd – 25th 2016; Cologne / Germany.

17.

Dregely I, Lanz T, Metz S, et al. A 16-channel MR coil for simultaneous PET/MR
imaging in breast cancer. European Society of Radiology. 2014;25:1154–1161.

18.

Schmitt M, Potthast A, Sosnovik DE, et al. A 128‐channel receive‐only cardiac coil
for highly accelerated cardiac MRI at 3 Tesla. Magn Reson Med. 2008;59(6):14311439.

19.

Paulus DH, Braun H, Aklan B, Quick HH. Simultaneous PET/MR imaging: MRbased attenuation correction of local radiofrequency surface coils. Medical physics.
2012;39(7):4306-4315.

20.

Fürst S, Souvatzoglou M, Martinez-Möller A, Nekolla S, Schwaiger M, Ziegler S.
Impact of MRI surface coils on quantification in integrated PET/MR. The Journal
of Nuclear Medicine. 2012;53(supplement 1):436.

21.

Ouyang J, Petibon Y, Huang C, Reese TG, Kolnick AL, Fakhri GE. Quantitative
simultaneous positron emission tomography and magnetic resonance imaging.
Journal of Medical Imaging. 2014;1(3):1-7, 7.

22.

Ferguson A. JM, YiSu, Debra Hewing, and Richard Laforest. Attenuation Effects
of MR Headphones During Brain PET/MR Studies. Journal of Nuclear Medicine
Technology. 2014;42:93–100.

23.

Eldib M, Bini J, Robson P, et al. Markerless attenuation correction for carotid MRI
surface receiver coils in combined PET/MR imaging. Physics in Medicine &
Biology. 2015;60(12):4705.

90

24.

Frohwein LJ, Heß M, Schlicher D, et al. PET attenuation correction for flexible
MRI surface coils in hybrid PET/MRI using a 3D depth camera. Physics in
Medicine & Biology. 2018;63(2):025033.

25.

Carney JP, Townsend Dw Fau - Rappoport V, Rappoport V Fau - Bendriem B,
Bendriem B. Method for transforming CT images for attenuation correction in
PET/CT imaging. American Association of Physicists in Medicine. 2006;33(4):976983.

26.

Patrick JC, Terry Thompson R, So A, et al. Technical Note: Comparison of
megavoltage, dual-energy, and single-energy CT-based μ-maps for a four-channel
breast coil in PET/MRI. Medical physics. 2017;44(9):4758-4765.

27.

Haacke EM, Wielopolski PA, Tkach JA, Modic MT. Steady-state free precession
imaging in the presence of motion: application for improved visualization of the
cerebrospinal fluid. Radiology. 1990;175(2):545-552.

28.

Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating
partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47(6):12021210.

29.

Henkelman RM. Measurement of signal intensities in the presence of noise in MR
images. Medical physics. 1985;12(2):232-233.

30.

Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: Sensitivity
encoding for fast MRI. Magn Reson Med. 1999;42(5):952-962.

31.

Robson PM, Grant Ak Fau - Madhuranthakam AJ, Madhuranthakam Aj Fau Lattanzi R, Lattanzi R Fau - Sodickson DK, Sodickson Dk Fau - McKenzie CA,
McKenzie CA. Comprehensive quantification of signal-to-noise ratio and g-factor

91

for image-based and k-space-based parallel imaging reconstructions. Magn Reson
Med. 2008;60:895–907.

32.

Price RR, Axel L, Morgan T, et al. Quality assurance methods and phantoms for
magnetic resonance imaging: Report of AAPM nuclear magnetic resonance Task
Group No. 1. Medical physics. 1990;17(2):287-295.

33.

Wiggins G, Triantafyllou C, Potthast A, Reykowski A, Nittka M, Wald L. 32‐
channel 3 Tesla receive‐only phased‐array head coil with soccer‐ball element
geometry. Magn Reson Med. 2006;56(1):216-223.

34.

Meise FM, Rivoire J, Terekhov M, et al. Design and evaluation of a 32‐channel
phased‐array coil for lung imaging with hyperpolarized 3‐helium. Magn Reson
Med. 2010;63(2):456-464.

35.

Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the
evaluation of signal-to-noise ratio performance with parallel imaging: Application
with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med.
2005;54(3):748-754

92

Chapter 3
3

Evaluation of 511keV Photon Attenuation from a Novel 32-

Channel Phased Array prospectively-designed for Cardiovascular
Hybrid PET/MRI Imaging.

3.1

Introduction

Simultaneous positron emission tomography (PET) and magnetic resonance imaging
(MRI) is a valuable tool for assessing different forms of cardiac diseases using PET tracers
sensitive to perfusion (13N-ammonia), inflammation or myocardial viability (18F-FDG), or
sympathetic innervation (11C-HED) in combination with MRI measurements of fibrosis,
function, and more. However, this value is tied to how accurately PET measurements can
be quantified and interpreted. A recent joint position statement from the European Society
of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine
(EANM)1, pointed out some unsolved issues of PET quantification in cardiovascular
hybrid PET/MRI imaging. The statement identified the need for high-temporal and spatial
resolutions for imaging of coronary atherosclerosis and other heart diseases. While,
accurate PET quantification is an ongoing topic of research, the root cause of inaccurate
quantification is usually associated with inaccurate attenuation correction (AC) inflicted
by one or more of; the method/models used for PET attenuation correction2-5; natural
motion due to patient respiration and heart activity6-8; and registration of flexible
hardware9-14. Notably, one of the causes of inaccurate quantification of PET is the radio

93

frequency arrays (mobile and/or flexible), which are required to achieve high-temporal and
spatial resolution in cardiovascular imaging. Photon attenuation from rigid and fixed arrays
can be accurately corrected for, using a dual-energy computed tomography-based AC map
(DCTAC)15, however one must consider the accuracy of the derived linear attenuation
coefficient (LAC) at 511keV.
The effect of a fixed phased array on PET quantification has been studied extensively9 and
it is reported that PET tracer activities were underestimated by 19% when the AC map was
not applied. Even when flexible phased arrays are designed to minimize attenuation,
deviations in PET quantification as large as 10%-15% were reported in regions of interest
adjacent to the flexible phased arrays11,12. Thus, applying AC map for flexible arrays is
ideal for accurate PET quantification in most applications. Thereafter, more studies were
dedicated to establishing a method to correct for attenuation of flexible arrays and in
particular the registration of the AC map to PET images. A method for accurate registration
of AC map of flexible RF arrays was developed and reported using fiducial markers to
guide the registration of the hardware AC map with the PET image11,12. Most recently, the
AC maps of flexible arrays were spatially registered using alternative methods without the
need for markers: 1) An automatic algorithm using data from an ultra-short echo time
(UTE) MRI scan14; 2) A method using the Microsoft Kinect V2 depth camera to track the
3D surface of the RF array and localize it inside the scanner’s FOV and determine hardware
AC map deformation parameters16. However, such approaches could not address the full
range of imaging conditions, for example, the marker methods require markers to be
present and fixed on the array during PET acquisition, which could affect the MRI images,
besides may cause inaccurate registration which may result to inaccurate quantification of
94

PET17. Meanwhile, offline algorithms used for AC and registration require dedicated
processors and are not straightforward for practical implementation in a clinical setting.
Moreover, all AC map registration methods have still produced regional PET images with
attenuation of >2.4%, and hence, the PET quantification issue remains unresolved when
using the standard arrays.
Knowing the effect of the vendor’s standard arrays on PET quantification, there is an urgent
need to develop and validate a PET- compatible cardiac array that does not require
hardware attenuation correction.
In a previous study we assessed a novel 32-channel, phased-array, prospectively-designed
for PET/MRI cardiovascular imaging, and reported that it was capable of achieving high
spatial and temporal resolution (up to acceleration factor R=6) for MRI imaging18.
In the present study, the same novel array is thoroughly evaluated for PET image quality
and compared to two standard arrays. Hardware AC maps for the posterior part of each
array were developed together with the NEMA-phantom AC map. In order to quantify the
effect of each part of the array on PET counts separately, NEMA Standard Publication NU
2-2001 for image quality measurements19 were performed using the anterior, posterior, and
both anterior/posterior parts of each of the three arrays, as well as, for no-array. Applying
attenuation correction during image reconstruction were performed using two approaches:
1) MRAC; where PET image reconstruction used MRI-based AC map for the liquid in
phantom, produced by the scanner, together with a dual-energy CT-based AC map for the
housing of the NEMA Body-Phantom. 2) DCTAC; where reconstruction of the PET image
used dual-energy CT-based AC maps for both the liquid in the phantom and the housing
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of the phantom. Although we report using two reconstruction approaches, the scope of the
study is not to compare the AC approaches. Instead, the two approaches were used to
demonstrate the PET performance of the novel array in the best-case scenario of attenuation
correction (DCTAC) and conventional PET reconstruction (MRAC) at low resolution.
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3.2

Materials and Methods

The method and some of the materials described here are adapted from NEMA Standard
Publication NU 2-2001 for PET image quality and accuracy of attenuation19, which has
been used for assessing image quality of PET systems and instrumentation20,21.

3.2.1

The arrays under evaluation and phantom

A NEMA Body phantom IEC-2007 (National Electrical, Manufacturers Association
Washington, DC, USA) was employed to carry out all PET quantification in this work
(figure 3-1-a). As shown in figure 3-1 (b, c, and d), the three arrays used in this study are;
the novel 32-channel PET/MRI array (Ceresensa, Canada 2016) consisting of two parts,
anterior (flexible) and posterior (fixed); the 12-channel mMR array (Siemens Healthcare
Limited, Erlangen, Germany) comprised of a 6-channel body matrix (flexible anterior) and
6-channel spine-matrix (fixed posterior); and the standard 32-channel MRI array (In-Vivo
Corporation, Gainesville, FL, USA) with anterior (flexible) and posterior (fixed) parts.

3.2.2

AC maps

In order to achieve accurate PET quantification, AC maps for all hardware within the
scanner must be developed and applied during attenuation correction, this includes the
NEMA phantom housing (i.e. phantom without its liquid content). Therefore, we
developed all necessary hardware AC maps using a Dual Energy CT (GE Healthcare,
Discovery CT750 HD, Waukesha, USA) scan of the hardware components following the
method of bilinear transformation of Hounsfield units (using mono-energetic
reconstruction at 70kVp and 140kVp) to 511keV linear attenuation coefficient22. The
developed DCTAC maps were for both the empty and filled NEMA body phantom and the
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posterior part of each array, while the spine-matrix array was excluded, since its AC map
is provided by the vendor.
For non-hardware AC maps, such as that related to the de-ionized water included in the
NEMA phantom, two scenarios were examined: 1) Rely on MRAC to correct for water
attenuation, with the rationale that this is the scenario of a non-research/ clinical study
where pre-acquired patient CT data is not normally available to the PET/MRI system; 2)
Develop DCTAC map for the phantom filled with water and use it for off-line attenuation
correction of the PET image, with the rationale that, this is the scenario of a research
setting, where patient PET/CT or CT-only data could be available for offline
reconstruction.

3.2.3

PET phantom preparation and measurements set-up

The phantom background is defined to be the phantom volume without the six sphericalinserts nor the lung-insert. The phantom background (volume ~10.2L) was filled with
deionized water and injected with

18

F-FDG to reach an activity concentration of

5.3±0.1kBq/ml. All six spheres (with inner diameters 10, 13, 17, 22, 28, and 37 mm) were
filled with

18

F-FDG to reach an activity concentration of 201±5kBq/ml, making the

phantom activities reach a 1:38 background-to-sphere ratio, where the background activity
corresponds to a typical injected dose for total body studies19.
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Figure 3-1:NEMA body phantom (a) together with the novel PET/MRI 32ch,
standard mMR12ch and MRI 32ch arrays.

NEMA IEC NU 2–2007
Phantom

PET/MRI 32ch

mMR 12ch

MRI 32ch

NEMA body phantom (a) together with the novel PET/MRI 32ch, standard
mMR12ch and MRI 32ch arrays (b, c and d respectively). The DCTAC maps for each
hardware showing here the axial central slice for the NEMA phantom with posterior
view of PET/MRI 32ch, mMR12ch and MRI 32ch arrays (e, f, g and h respectively).
All µ-maps are windowed to the same level.

Markers were produced on the patient table, as well as the phantom body, and when both
markers were matched the same position of the phantom on the table was consistently
achieved with +/- 1mm tolerance. During all measurements, the isocenter was selected to
be at the center line between position number 4 and 5 of the spine-matrix (marked on the
patient table). This set-up ensured that no additional objects employed for positioning
during the PET measurement and hence, data are free from added errors. The set-up also
ensured the elimination of attenuation variation that the patient table itself may contribute.
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3.2.4

Image acquisition and attenuation correction

For ease of reading throughout this manuscript, the anterior part of an array is denoted with
letter A while the posterior part is denoted with letter P, and therefore both parts of an array
are denoted with A&P, and part(s) may be referred to as case(s).
All PET acquisitions were performed on a 3.0T PET/MRI system (Biograph mMR
Software Version VE11P, Siemens Healthineers, Erlangen, Germany), and followed the
identical workflow routine.

Evaluation of one complete array required one imaging

session consisting of four PET measurements, where the first measurement was started
once the activity reached the concentration described above. Each measurement comprised
of a Dixon MRAC acquisition (2.5min) and a PET acquisition (10min). The four PET
measurements were carried out in the following order: 1) the complete array (A&P) and
NEMA phantom; 2) the posterior part (P) of the same array and NEMA phantom; 3) the
anterior part (A) of the same array and NEMA phantom; 4) the NEMA phantom with noarray. Two imaging sessions were performed for each array, yielding two data sets for data
analysis.

3.2.4.1

MRAC

By MRAC, here, we refer to the PET/MR scanning conditions where only the posterior
part of the array and the patient table hardware AC maps, together with MR-based AC map
of the liquid in the phantom, are used for PET attenuation correction during image
reconstruction. A MRAC map of the liquid portion of the NEMA phantom was acquired
with the manufacturer’s standard 2-point Dixon (3D dual-echo spoiled gradient sequence)
using, TR/TE=4.14/2.51, Matrix size=240x126x127 at a resolution of 2.08x2.08x2.02 mm3
and is intrinsically registered to the PET images. The AC maps of each array’s posterior
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part along with the NEMA phantom housing were registered to the scanner offline. For
clarity, the reconstruction of the no-array AC images on the scanner used the phantom
housing and patient table hardware AC maps, together with the phantom water MRAC
map. The Biograph mMR’s standard PET reconstruction algorithm, an Ordinary PoissonOrdered Subsets Expectation Maximization (OP-OSEM)23 approach, was applied using 3
iterations, 21 subsets, and a 4mm Gaussian filter.

3.2.4.2

DCTAC

In order to obtain the ideal AC for both the hardware and liquid portion of the NEMA
phantom, the raw, nonattenuation-corrected (NAC) data of each measurement was
reconstructed offline using DCTAC of the NEMA phantom including the liquid portion
and other hardware DCTAC maps. All PET reconstructions were performed offline using
the manufacturer’s e7-tools (Siemens Molecular Imaging, Knoxville, USA). The PET
images were reconstructed using the same algorithm and parameters as described under the
MRAC section above. The PET images output matrix size, which was 344x344x127 to
achieve ideal reconstruction modality21.

3.2.5

Data analysis

All data were corrected for the PET decay, due to the time used for hardware changing and
sequence set-up, scatter and attenuation, before carrying out the analysis. All image
processing and data analysis were computed using Matlab 9.3.0 (The MathWorks, Natick,
MA, USA).
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3.2.5.1

NAC data

NAC data are important in this analysis since it does not include any errors that an AC
process might introduce. From NAC data, the global mean and standard deviation of each
masked image (slice) were estimated. This mean and standard deviation were estimated for
all cases of the three arrays, as well as for the no-array. The no-array data was considered
the frame of reference that each part of an array was compared to. Therefore, relative
percentage differences (RPD) between no-array and each part of an array were estimated
and reported using equation 4 as reported in18 and presented here for convenience, where

𝒗𝟏 is the no-array case and 𝒗𝟐 is any given case (A, P or A&P).

𝑹𝑷𝑫 =

3.2.5.2

𝒗𝟏 − 𝒗 𝟐
100%
𝟎. 𝟓 (𝒗𝟏 + 𝒗𝟐 )

AC data

According to the NEMA NU 2–2001 standard, PET image quality can be analyzed from
parameters such as contrast recovery (CR), background variability (BV) and contrast-tonoise ratio (CNR). Therefore, each sphere’s CR, BV and CNR were estimated from the
relationships described in19, and the mean and standard deviation for each array and for noarray were computed and reported. Relative percentage difference maps between PET
images from no-array and images from each array part were computed. PET image quality
parameters were estimated for both scenarios of AC data; images reconstructed by the
scanner and images reconstructed offline using e7-tools. Statistical evaluation of the
resulting means used a one-factor analysis of variance (ANOVA) with ‘array’ as the
102

between-subject factor (alpha = 0.05). In the null hypothesis, no significant differences
exist between all three arrays (equal means), and in the alternative hypothesis, means are
significantly different with no a priori direction. The test was applied on the data from each
array part (A, P and A&P) and the degree of freedom, F-factor and p-values are reported.

3.3

Results

This study focused on assessing each part of the novel array independently for global and
regional attenuation through PET image quality indicators and compared it to the no-array
data as a frame of reference. The study particularly aimed to quantify the attenuation effects
of the flexible (anterior) part of the array, since registration of its AC map is typically
considered a great challenge likely to be alleviated by the use of essentially PETtransparent anterior parts.

3.3.1

AC maps

The NEMA-phantom is shown in figure 3-1-a, and the array under evaluation in fig. 3-1-b
together with the two standard arrays fig. 3-1-c and d. Figure 3-1- e, f and h, demonstrate
the in-house developed DCTAC maps for the NEMA phantom, the novel 32ch posterior,
and the MRI 32ch posterior array respectively, while figure 3-1-g shows the spine-matrix
AC map provided by the vendor. All posterior AC maps are shown with added patient table
and NEMA phantom map which are used during PET image reconstruction on the scanner.
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3.3.2
3.3.2.1

Global means
NEMA Phantom NAC data

Figure 3-2- a, c and e, show the NAC data acquired for each of the three arrays PET/MRI
32ch (novel), mMR 12ch, and MRI 32ch respectively, where the decay-corrected mean of
each image counts-per-second (CPS) in the z-plane are plotted, for each array parts A, P,
A&P and no-array. The RPD between each part of an array and no-array are shown in
figure 3-2- b, d and f. It is observed that the novel array demonstrated a steady RPD < 5%
in all cases of A, P, and A&P. The RPD for both standard arrays varied between 4% and
19%. The detailed RPD of the global mean for each array and its parts are reported in table
3-1.

104

A

P

A&P

1.9±0.6

3.0±0.7

4.3±0.7

MRAC%

32ch

2.1±0.8

0.7±3.1

1.5±3.9

DCTAC%

1.9±0.9

-1.8±3.5

0.0±2.5

NAC%

7.3±2.3

8.7±1.3

15.6±1.4

MRAC%

12ch

4.8±0.9

10.7±3.6

13.4±3.4

DCTAC%

4.6±1.2

-3.7±2.8

2.8±2.6

NAC%

8.9±1.5

5.8±2.2

15.3±1.9

32ch

p-value

MRI

mMR

PET/MRI

Table 3-1: RPD of the global means for each case A, P, and A&P.

MRAC%

8.3±0.9

5.6±1.5

7.4±8.2

DCTAC%

7.9±1.3

-2.4±3.6

9.5±2.7

MRAC

0.001

0.014

0.008

DCTAC

0.001

0.050

0.121

NAC%

RPD of the global means for each case A, P, and A&P; NAC, reconstructed with
MRAC and DCTAC. The negative value represents over-correction of attenuation.
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Figure 3-2: Non attenuation correction (NAC) and relative percentage difference
(RPD) plots for each array for all cases A, P, A&P.

NAC data are shown in the left column of the figure, with plots showing as counts-per-second
vs the acquisition plane number for all cases A, P, A&P and no-array. Plots are for a) the
novel PET/MRI 32ch, c) the mMR 12ch, and e) the MRI 32ch arrays. The right column
includes the corresponding RPD plots for each array (b, d, and f) at case A, P and A&P.
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3.3.2.2

MRAC

In table 3-1 RPD of global means are also reported for each case of each array, where RPD
for A&P-MRAC case for the novel array is estimated to be 1.5% compared to 13.4% and
7.4% for the same case with the mMR 12ch and MRI 32ch respectively.
Figure 3-3-i shows the MRAC constructed PET images obtained on the NEMA-phantom
with the four cases no-array, A, P, and A&P labelled for each array, all spheres are visible.
In figure 3-3-ii RPD maps are shown for the three arrays, which are the results of
comparing each case of an array with no-array, by means of percentage difference by pixelby-pixel approach. In figure 3-3-ii also, the RPD from the anterior part of the novel array
ranged from -0.5% to 1.0%, while the RPD from mMR 12ch and MRI 32ch ranged from 1.4% to 19.3%.

3.3.2.3

DCTAC

The global mean of RPD between each case vs no-array using the DCTAC reconstruction
are reported in table 3-1. The RPD of global means, for both mMR 12ch and MRI 32ch, in
case P, are -3.7% and -2.4% respectively, while for the novel array it is -1.8%. The A&P
case for the novel array produced a global mean RPD of 0.0%, compared to 2.8% and 9.5%
for the standard arrays. In figure 3-3-iii the NEMA phantom images reconstructed using
the DCTAC for all cases as well as no-array with all spheres showing. Figure 3-3-iv, shows
the RPD maps for all cases of each array resulted from their DCTAC data, where the lowest
regional variations belong to the novel array A case. The RPD from both mMR 12ch and
MRI 32ch in figure 3-3-iv, shows high regional variation in case A (close to the top of the
RPD maps), which was not the case of the novel array.
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Figure 3-3: Reconstructed AC images of the NEMA-phantom and RPD maps for all cases (no-array, A, P, A&P).

PET/MRI 32ch

A&P

ii

iii

iv

mMR 12ch

PET/MRI 32ch

MRI 32ch

mMR 12ch

i

Relative Difference Maps
A
P
A&P

MRI 32ch

Off-line (DCTAC) reconstruction

MRAC reconstruction

PET Activities from NEMA-phantom
No-Array
A
P

Images in (ii) and (iv) are the RPD maps corresponding to MRAC and DCTAC.

3.3.3

Image quality

PET image quality parameters CR and BV using the MRAC reconstructions, for each array
and each case are shown in figure 3-4 – a, c and e. Background variation with the smallest
range and magnitude was found in the novel array. The contrast recovery for case P of the
MRI 32ch array is measured to be 83.6% for the 37mm sphere, superseding the contrast
recovered by no-array for the same sphere size. From the MRAC data, the percentage of
background variation for the MRI 32ch were found to be in a range between 8.3% and
9.0% for the 10mm sphere and between 10.0% and 11.0% for the 37mm sphere, which
were higher compared to the novel array.
In figure 3-4-b, d, and f, the image quality parameters BV estimated from DCTAC data are
plotted for all parts of the arrays. BV from the A&P case of the novel array reported to be
the lowest in all data.

Figure 3-4: Contrast recovery vs. background variation (from six spheres) for each
array.
AC (MRAC)

AC Off-line (DCTAC)

The PET images for this analysis was reconstructed using both MRAC (a, c and e)
and DCTAC (b, d and f).
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3.3.4

Anterior analysis

Table 3-2 lists the relative differences between no-array contrast recovery and each array’s
anterior (A case) for all spheres, where the lowest RPD for sphere sizes 10mm, 22mm, and
37mm using the MRAC data, was for the novel array. The case A of the novel array
recorded the lowest RPD across all sphere sizes, as seen from the DCTAC data in table 32.
Figure 3-5-a is a histogram combined with line plot (solid line plot) presenting the CNR
from DCTAC data for case A of each array together with the no-array, as reference. The
novel array anterior part is found to have the closest CNR values to the reference array
for all sphere sizes. Both the MRI 32ch and the mMR 12ch surpasses, or are lower than,
the no-array reference. The BV and CR from the MRAC data from case A for all sphere
sizes are plotted in figure 3-5 b and c respectively. The BV produced by the novel array
has recorded the closest values to the no-array data with BV ranging from 7.5% at 10mm
sphere to 8.9% at 37mm sphere. Following the same pattern, the CR values were found to
be the closest to no-array with range from 14.7% to 62.8%.

111

Table 3-2: CR relative percentage difference between no-array and the anterior (A)

DCTAC

MRAC

part of each array for each sphere size.
Sphere size (mm)

10

13

17

22

28

37

PET/MRI 32ch (%)

4.8

2.8

5.2

3.8

2.1

-1.5

mMR12ch (%)

15.1

2.6

-4.0

-5.4

2.0

5.2

MRI 32ch (%)

-20.2

-17.9

-22.7

-16.4

-13.1

-17.3

p-value

0.003

0.01

0.00

0.001

0.00

0.00

PET/MRI 32ch (%)

3.8

0.9

3.6

2.0

3.7

2.4

mMR12ch (%)

6.0

8.0

4.1

3.5

4.2

6.6

MRI 32ch (%)

-10.6

-7.7

-9.5

-11.1

-6.8

-6.2

p-value

0.007 0.011 0.129 0.053 0.050 0.001

The CR was estimated for both reconstruction methods (MRAC and off-line
DCTAC).

3.3.5

Data analysis

Differences between mean activities for each case (A, P or A&P) of the three arrays were
tested with 1x3 one-factor ANOVA using the array as a factor. For the case A&P, there
was no statistically significant difference between group means as determined by one-way
ANOVA (F(2,6) = 3.0, p = 0.121). For the cases of A and P, there were statistically
significant differences between group means as determined by ANOVA (F(2,6) = 33.1, p
= 0.001) and (F(2,6) = 4.2, p = 0.050) respectively.
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Figure 3-5: CNR, BV and CR data for each anterior component of the three arrays
are compared to no-array for all spheres.
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3.4

Discussion

In this work, a novel array prospectively designed for hybrid PET/MRI cardiovascular
imaging, was evaluated for 511keV photon attenuation. The evaluation incorporated a
comparison of the novel array PET performance measuring PET image quality parameters
using the NEMA NU 2-2001 Body Phantom compared to a reference measurement (noarray). The novel array’s separate parts were also assessed individually and together and
compared to its counterparts from two standard arrays currently used in PET/MRI
cardiovascular imaging. Two different PET image reconstruction techniques (MRAC and
DCTAC) were used to assess the novel array performance in the context of non-research
(clinical) and research settings.
To date, research on hardware performance in PET/MRI environment, specifically RF
phased arrays, have been focusing on flexible/mobile anterior part, since it is the most
challenging for AC11-13. Nevertheless, in this study, all configurations/settings of the array
(A, P or two parts A&P) were evaluated for each of the three arrays. This was fair since
the setting for simultaneous PET/MRI cardiovascular imaging utilizes both anterior and
posterior parts of an array. However, we chose not to produce DCTAC maps for the
anterior part of each array, nor to apply the AC maps during PET image AC reconstruction,
in order to mimic the non-research setting (clinical).
Notably, the results obtained in this study for the anterior part of both standard arrays are
in agreement with previously reported results by11-13. The anterior part only of the mMR
12ch array caused overall loss of counts of 4.7% (table 3-1), and may cause up to 2.55%
residual error after applying AC maps and utilizing specially developed algorithms to
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reconstruct PET images off-line, as reported by11. Similarly, for the MRI 32ch anterior
case, it was reported by13 that loss of true counts could be as high as 10%, while regionally
estimated to be as high as 22% and as-low-as 2.7% globally, after correction using CTbased AC map and using a complex algorithm off-line. Both standard arrays anterior parts
affected the PET images, which is emphasised by the high values in the RPD map and are
visible in (fig. 3-3, ii and iv). These effects are found to be in agreement with the results
reported by12.
In this study we have shown that the novel array anterior has a superior performance (≤ 2%
RPD) with no attenuation correction maps applied, while both A&P attenuates less than
2.5% together after posterior-correction. Although no AC-map for the anterior of the novel
array was used, the array had not affected the PET images, which was confirmed by RPD
map homogeneity and low regional variation.
This, in comparison to its counterparts from the two standard arrays (mMR 12ch and MRI
32ch), is considered to be advantageous, in the sense that no registration is needed. Such
advantage was significant (p=0.001) for the anterior, though the A&P case for the three
arrays difference was not significant (p=0.121). At first, this may suggest that the
attenuation from the complete A&P set for all arrays are not significantly different.
However, upon a closer inspection AC data (fig. 3-4 d, e and f) of the P case and RPD
maps (fig. 3-3 ii and iv) for both standard arrays, one notices that the AC map of the
posterior parts are over correcting, which is contradicted by the underestimated attenuation
caused by the anterior part. Hence, AC map of the anterior part is necessary when using
the A&P set for better global attenuation estimation.

Considering the background

variability as a representation of PET image homogeneity, the novel array can achieve the
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highest image homogeneity, since it produced the lowest BV. The BV is also a measure
of statistical noise in the image confirming that the novel array causes the least noise (e.g.,
from inaccurate attenuation correction or poor convergence during iterative
reconstruction).

3.5

Conclusions

This study presented the PET performance of a novel 32ch RF phased array, prospectivelydesigned for hybrid PET/MRI cardiovascular imaging. Although the novel array has 32
elements (almost 3 times more than the mMR 12ch), yet, we have shown that the novel
array had better attenuation qualities that resulted in better PET images. The results from
this study together with MRI-performance of the same array reported in18 suggests its
suitability for PET/MRI cardiovascular imaging. This novel array can operate without
needing AC for the anterior part, simplifying the attenuation correction while at the same
time improving PET image quality.

116

3.6

Acknowledgement

The authors gratefully acknowledge: Funding from MITACS (Application Ref. IT12869)
(to JThé), an industry-sponsored internship (to AF) in collaboration with Multi Magnetics
Inc (London, Ontario, Canada). partial salary support of AF by NSERC Discovery Grant
(No. RGPIN-2016-05055) (to JThé), infrastructure support by Ontario Research Fund
(RE07-021) (to FSP) and by Canada Foundation for Innovation Grant (11358) (to FSP).
The authors would like to thank Mr. John Butler, MRT for his assistance with obtaining
radioactive tracers.

117

3.7
1.

References
Nensa F, Bamberg F, Rischpler C, et al. Hybrid cardiac imaging using PET/MRI:
a joint position statement by the European Society of Cardiovascular Radiology
(ESCR) and the European Association of Nuclear Medicine (EANM). European
Journal of Hybrid Imaging. 2018;2(1):14.

2.

Catana C, van der Kouwe A, Benner T, et al. Towards Implementing an MR-based
PET Attenuation Correction Method for Neurological Studies on the MR-PET
Brain Prototype. J Nucl Med. 2010(0161-5505 (Print)).

3.

Ghadiri H, Shiran MB, Ay MR, Soltanian-Zadeh H, Rahmim A, Zaidi H. A novel
energy mapping approach in CT-based attenuation correction of PET data using
multi-energy CT imaging. Paper presented at: 2011 IEEE Nuclear Science
Symposium Conference Record; 23-29 Oct. 2011, 2011.

4.

Marshall HR, Patrick J, Laidley D, et al. Description and assessment of a
registration-based approach to include bones for attenuation correction of wholebody PET/MRI. Medical physics. 2013;40(8):082509.

5.

Wagenknecht G, Kaiser H-J, Mottaghy FM, Herzog H. MRI for attenuation
correction in PET: methods and challenges. Magnetic Resonance Materials in
Physics, Biology and Medicine. 2013;26(1):99-113.

6.

Kolbitsch C, Prieto C, Tsoumpas C, Schaeffter T. A 3D MR-acquisition scheme for
nonrigid bulk motion correction in simultaneous PET-MR. Medical physics.
2014;41(8Part1):082304.

118

7.

Huang C, Ackerman JL, Petibon Y, et al. Motion compensation for brain PET
imaging using wireless MR active markers in simultaneous PET–MR: Phantom and
non-human primate studies. NeuroImage. 2014;91:129-137.

8.

Lindemann ME, Nensa F, Quick HH. Impact of improved attenuation correction on
18F-FDG PET/MR hybrid imaging of the heart. PLoS One. 2019;14(3):e0214095.

9.

MacDonald LR, Kohlmyer S, Liu C, Lewellen TK, Kinahan PE. Effects of MR
surface coils on PET quantification. Medical physics. 2011;38(6):2948-2956.

10.

Fürst S, Souvatzoglou M, Martinez-Möller A, Nekolla S, Schwaiger M, Ziegler S.
Impact of MRI surface coils on quantification in integrated PET/MR. The Journal
of Nuclear Medicine. 2012;53(supplement 1):436.

11.

Paulus DH, Braun H, Aklan B, Quick HH. Simultaneous PET/MR imaging: MRbased attenuation correction of local radiofrequency surface coils. Medical physics.
2012;39(7):4306-4315.

12.

Kartmann R, Paulus DH, Braun H, et al. Integrated PET/MR imaging: Automatic
attenuation correction of flexible RF coils. Medical physics. 2013;40(8):082301.

13.

Eldib M, Bini J, Calcagno C, Robson PM, Mani V, Fayad ZA. Attenuation
Correction for Flexible Magnetic Resonance Coils in Combined Magnetic
Resonance/Positron Emission Tomography Imaging. Investigative radiology.
2014;49(2):63-69.

14.

Eldib M, Bini J, Robson P, et al. Markerless attenuation correction for carotid MRI
surface receiver coils in combined PET/MR imaging. Physics in Medicine &
Biology. 2015;60(12):4705.

119

15.

Patrick JC, Terry Thompson R, So A, et al. Technical Note: Comparison of
megavoltage, dual-energy, and single-energy CT-based μ-maps for a four-channel
breast coil in PET/MRI. Medical physics. 2017;44(9):4758-4765.

16.

Frohwein LJ, Heß M, Schlicher D, et al. PET attenuation correction for flexible
MRI surface coils in hybrid PET/MRI using a 3D depth camera. Physics in
Medicine & Biology. 2018;63(2):025033.

17.

Eldib M, Bini J, Faul DD, Oesingmann N, Tsoumpas C, Fayad ZA. Attenuation
Correction for Magnetic Resonance Coils in Combined PET/MR Imaging. PET
Clinics. 2016;11(2):151-160.

18.

Farag A, Thompson RT, Thiessen JD, Butler J, Prato FS, Théberge J. Assessment
of a novel 32-channel phased array for cardiovascular hybrid PET/MRI imaging:
MRI performance. European Journal of Hybrid Imaging. 2019;3(1):13.

19.

NEMA N-NEMA. Performance Measurements of Positron Emission Tomographs,
NEMA Standards Publication NU 2-2001. In: Publication NS, ed. Rosslyn, VA
22209: International and Pan American; 2001.

20.

Daube-Witherspoon ME, Karp JS, Casey ME, et al. PET Performance
Measurements Using the NEMA NU 2-2001 Standard. Journal of Nuclear
Medicine. 2002;43(10):1398-1409.

21.

Ziegler S, Jakoby BW, Braun H, Paulus DH, Quick HH. NEMA image quality
phantom measurements and attenuation correction in integrated PET/MR hybrid
imaging. EJNMMI Physics. 2015;2(1):18.

22.

Carney JP, Townsend Dw Fau - Rappoport V, Rappoport V Fau - Bendriem B,
Bendriem B. Method for transforming CT images for attenuation correction in

120

PET/CT imaging. American Association of Physicists in Medicine. 2006;33(4):976983.

23.

Comtat C, Bataille F, Michel C, et al. OSEM-3D reconstruction strategies for the
ECAT HRRT. Paper presented at: IEEE Symposium Conference Record Nuclear
Science 2004.; 16-22 Oct. 2004, 2004.

121

Chapter 4
4

Improved PET/MRI accuracy by use of static transmission

source in empirically-derived hardware attenuation correction.

4.1

Introduction:

Hybrid positron emission tomography (PET) and magnetic resonance imaging (MRI)
systems are becoming increasingly important in cardiovascular diagnostic imaging1. In
cardiac PET/MRI, accurate measurement of PET activity is necessary for evaluating
cardiac function2 and inflammation3,4, and grading tumors based on their standardizeduptake-values (SUV)5. One aspect that affects the accuracy of PET quantification is the
attenuation of photons absorbed by fixed or mobile hardware present during scans, such as
RF arrays, the patient table, and headphones. The adverse effects of such hardware on PET
quantifications has been reported numerously in publications; for example, the patient table
of the PET/MRI system causes up to 18.7% loss of PET true-counts 6, while RF resonators,
for the same system, caused true-count losses varying between 3% to 14%7-13.
In addition to the patient AC map, it is necessary to include AC maps of hardware present
in the PET field of view (FOV) during the scan. However, unlike patient AC maps, which
can be determined using an MRI attenuation correction acquisition (MRAC)14, hardware
is often invisible to MRI. To overcome such hardware attenuation, it is often required to
prospectively-redesign some hardware (i.e. rigidly fixed RF arrays) for simultaneous
PET/MRI, aiming to reduce their photon attenuation9. However other hardware, such as
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the patient table, would be challenging to redesign, and hence techniques to correct their
attenuation is still a topic of study.
In a PET-only system, the challenge of hardware AC is addressed through transmission
scan that can be carried out after patient injection with the emission tracers or,
simultaneously as transmission-emission scans15. In this setting, a rotating rod containing
a radioactive source either emitting positrons (Ge-68/Ga-68)16 or a source emitting a single
photon (Cesium-137)17, is utilized to map the hardware for attenuation. Meanwhile in an
integrated PET/CT system, this challenge is simpler, since hardware is visible on the CT
scan, and hence, CT images can be used to map hardware attenuation. To produce CTbased AC of hardware, the CT HU are converted and scaled into LAC of PET annihilation
photon energies (511keV), which are estimated by either, a bilinear transformation model
from a single CT energy (140kVp)18, from a dual-energy CT to PET energy level19-22, or
multi-energy CT imaging23. The bilinear model is based on different slopes for air-water
(HU < 0) and water-bone (HU > 0). Although, the bilinear transformation model of CTHU to PET LAC is optimized for densities ranging from air-to-bone, it is still employed in
AC of hardware on PET/MRI system. This led to an attempt to improve the model and
address material with high atomic number (Z) (Oehmigen et al., 2020), nevertheless the
group reported general limitations when larger amounts of highly attenuating materials are
to be corrected. While CT-based attenuation correction is the silver-standard for hardware
AC of PET images, with CT-based AC, images still have errors up to 4.7%24. Causes of
these errors invoke the use of a broad polychromatic spectrum X-ray at lower photon
energies for CT image acquisition, unlike PET image acquisition, which is monochromatic.
Hence, the transformation of HU to LAC at 511keV requires extensive energy mapping.
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Additionally, the polychromatic X-ray in CT can cause beam hardening artefacts,
especially with materials with a high atomic number (e.g. electronics found in hardware),
which further degrades the measurement of accurate attenuation coefficients23.
With this in mind, TX-based AC has an advantage as an alternative to CT-based AC
methods for PET/MRI systems. The transmission-based AC is based on acquiring a
“blank” scan (without the hardware), and a transmission scan (with the hardware), where
the ratio of the two scans, in simple terms, is the LAC. The method based on a rotating
radioactive source “rod” to produce AC maps on PET and PET/CT systems has been used
for decades21,25. However, it is not possible to incorporate the rotating rod into the
PET/MRI system, due to complexity of the system design. Furthermore, the ability to
reduce radioactive dose with MRI in PET/MRI would be diminished if a radioactive source
is used to measure the tissue and hardware AC. It would also increase the scan time, which
would further diminish the advantages of simultaneous PET/MRI. As an alternative to the
rotating rod, liquid fluoro-deoxy-glucose (18F-FDG) was injected in an annulus-shaped
phantom tube that circumfused the hardware and was used as a transmission source26.
However, this alternative transmission method required more complex algorithms to allow
the simultaneous reconstruction of emission and transmission data.
This study aims to propose TX-based AC using a “uniform and static” radioactive source
(Ge-68 rod) for generating AC maps for hardware used in PET/MRI systems as alternative
to using CT or rotating radioactive source techniques. Thus, the novelty of this study is to
develop a new technique using a uniform-static source for LAC estimation of hardware
like a patient table or RF arrays.
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4.2
4.2.1

Materials and Methods:
Theory

The linear attenuation coefficient (µ) describes the fraction of photons from a
monoenergetic gamma ray that is attenuated by material, per unit path length (l). This is
expressed as the ratio of the number of photons detected (I) by the PET detector along the
line of response (LOR) with the hardware in place, to the number of photons detected (I0)
from a blank scan (without the hardware), and is described as:

𝑰
𝑰𝟎

= 𝒆−𝝁𝒍

[1]

In the case of a PET TX-scan of hardware for coincident detection of photon at any
detector, eq (1) can be written in a discreet form of Lambert’s law:

𝑰
𝑰𝟎

= 𝒆− ∑𝒑 𝝁𝒊,𝒋 (𝒑).𝒍𝒊,𝒋 (𝒑)

[2]

Where i is the detector index, j is the voxel index, and p is the hardware voxel position in
the PET FOV (figure 4-1). Since both LAC and path length are functions of position, in a
PET-only scanner a rotating rod at multiple locations can provide the position of each point
of the hardware, and the partial path length is known. In this study, we chose to use a
known position of the radioactive source (Ge-68 rod), at the center of the bore (along x, y
and z axis), this together with knowing the locations of the detectors27 and 3D data profile
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of the hardware, the partial path length at each point in the hardware can be calculated.
Therefore, the hardware profile was registered to known voxel-size and voxel-positions,
which together with the known position of the radioactive source, each position indices
have a partial path length at a given LOR which can be estimated using the following
relation:

𝒍𝒊,𝒋 = ∑𝒑 𝒅𝒊 (𝒑). 𝒃𝒋 (𝒑)

[3]

Where d is the voxel size, and b = 1 when a voxel contains a hardware profile and is
otherwise equal to 0. Since position indices and partial path length projected are known,
LAC can now be estimated and assigned to each voxel.
Figure 4-1: Illustration of physical relation of hardware voxels position (p) along a
LOR and corresponds to voxel indices (j) and detector indices (i).
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4.2.2

Acrylic cylinder and TX-fixture

In order to test the proposed method accuracy, one must confirm the LAC value measured
by the method with a known theoretical LAC value of a known material. For this purpose,
a phantom and a fixture to hold both the phantom (empty acrylic cylinder) and the
radioactive source were reconstructed. To align the source in a known position and
maintain consistent position in all scans, a fixture, namely a TX-fixture, was developed to
hold the rod with better than 1mm tolerance. The TX-fixture, utilizes the vendor’s dailyQC phantom holder for mounting to the table at any position. The TX-fixture was designed
to hold and secure multiple or single rod (s) of Ge-68; 37 MBq; (Sanders Medical, USA),
where the rod has an outer diameter of 8mm and a length of 280mm. It also permits
attaching the cylinder and the rod together or each individually as seen in figure 4-2, a, b
and c. Cylinder material selection criteria as an attenuation validator, included: known
LAC value at 511keV, geometric symmetry, synthetic / controllable chemical contents. We
chose acrylic with purity of 99.99% and known chemical composition (C5O2H8). The
cylinder was hollow with the exception of a series of circular holes at its bases where the
rod source was positioned. The cylinder was manufactured with; 9mm wall thickness, 210
mm length and 310mm diameter (figure 4-2-b).
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Figure 4-2: The apparatus (TX-fixture) and setting used in PET acquisitions.

In this figure, a) schematic of the TX-fixture showing the radioactive Ge-68 rod
positioned in the center, during blank scan, b) both the acrylic cylinder phantom and
the rod attached to the TX-fixture, and c) the QC-daily phantom holder securing the
TX-fixture to achieve a reproducible position on the patient table.

4.2.3

TX-based AC

In figure 4-3 a flow chart of the steps followed to produce TX-based AC map is shown. A
set of PET TX acquisitions was performed post QC-daily normalization routine on a 3.0T
PET/MRI system (Biograph mMR Software Version VE11P, Siemens Healthineers,
Erlangen, Germany). The TX acquisition included; 1) a blank acquisition of the rod,
centered by the TX-fixture in the bore, with no-table or other hardware in the PET-FOV,
therefore photon counts can be used as a reference and becomes the target to reach; 2) a
TX scan with the cylinder attached to the TX-fixture with the rod in the same position as
the blank TX scan. The time between the two scans, blank and with hardware, was
approximately 7 min resulting to ~0.0009% decay of the Ge-68 activities, and therefore
decay correction was ignored. For patient MRAC, a two-point Dixon, 3D spoiled gradient
sequence using, TR=4.14ms, TE=2.51ms and 1.2ms, Matrix size=240x126x127, was
acquired to generate a tissue AC map with segmentation of air, lung, water, and fat. A PET
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acquisition was performed for 5 minutes with matrix size 344x344x127 at a resolution of
2.09x2.09x2.02 mm3. PET reconstruction on the scanner was performed by an Ordinary
Poisson Ordered Subsets Expectation Maximization (OP-OSEM) algorithm28 including 3
iterations, 21 subsets, and a 4mm Gaussian filter. For derivation of the TX-based LAC of
the cylinder a 3D-CAD profile was scaled to the same parameter as that of the PET
acquisition and registered to image voxel. The partial path length of each voxel along the
LOR to each detector was calculated from a simulated PET-FOV of the scanner geometry
(8 rings each including 56 detectors at a rotating angle of ~= 6.4°)27. Positioning the rod at
the center of both the PET-FOV and the cylinder, allowed for symmetrical and
homogeneous conditions, and therefore the distance between the source and a detector
could be treated as a constant at a given plane number. Therefore, partial path lengths were
assumed to be unchanged across planes for a given voxel. The resultant TX-based AC map
was used with list-mode data, from the TX scan of the cylinder, to reconstruct the PET
images.
Although scatter correction is not in the scope of this manuscript, however, it was assumed
in this study that scatter has no dominant effect, since scatter depends on the source
distribution which is homogenous in this case.
All offline PET reconstructions using TX-based AC in this study were performed using the
manufacturer’s offline reconstruction tool (e7-tools, Siemens Molecular Imaging,
Knoxville, USA).
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Figure 4-3 Flow chart describing the process of generating hardware TX-based AC
map.

In this process, the hardware µ-map is generated using the PET/MRI scanner and a
static radioactive source.

4.2.4

Theoretical LAC of acrylic

To verify the accuracy and validity of the TX-based LAC derived for the cylinder, we used
the "un-renormalized" Scofield (1973) theoretical values of the photo-effect cross section
for all elements with atomic number Z ≥ 2 of the acrylic chemical composition. The
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analytical results used for Z = 1 are the same as those used in the29 compilation. LAC of
acrylic was mapped at energy levels in the range between 0.1 and 1.0 MeV, where LAC
was subsequently interpolated at 511 keV using 4th order polynomial fitting.

4.2.5

CT-based AC

The cylinder was scanned using Dual-Energy CT (GE Healthcare, Discovery CT750 HD,
Waukesha, USA), with the following parameters: tube voltage = 140 and 70 kVp; tube
current = 630 mA; pitch = 0.515625 degree; FOV= 60 x 60 cm2; and exposure time = 912
seconds. The HU were converted to LAC at 511 keV using a bilinear model19. The CTbased AC map was used together with the nonattenuation-corrected (NAC) of the cylinder
to reconstruct the cylinder AC images offline.

4.2.6

Validation of the technique

The validation criteria of the technique were identified as the agreements of PET total
photon counts and distribution between both TX-based AC of the cylinder, and the blank
AC. We have selected an agreement threshold of ≤ 1%, aiming to improve attenuation
accuracy over the CT-based AC method which is currently achieving (2.7%). After
validating the technique, it was applied to the posterior part of the 32-channel cardiac array
and the patient table.

4.2.7

Posterior array

The same procedure as described above was performed to derive the hardware AC map of
the posterior part of the cardiac array. However, the hardware profile was derived from a
3D-CT map9. The posterior profile was created by transforming the maps into binary values
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where each voxel containing posterior information was assigned 1, otherwise 0. In this TXscan the posterior array was placed in the bore and positioned on the patient-table rails.
The targeted area, including the elements, were centered in the PET-FOV, and with this
setting the TX scan of the posterior array, without the patient table, matched the location
of the posterior array when used for cardiovascular imaging.

4.2.8

Patient table

We chose the patient table area in this study to be centered between the S2 and S3 markings
on the patient table which normally relates to the position of the elements of the spine
matrix for this scanner. This allowed a consistent and match of the locations of the posterior
array, table and cardiac patient during AC reconstruction using the TX-based AC maps.
For this setting the daily-QC phantom holder was mounted to the patient table, with no
other object present, and the TX-scan was performed as described earlier.

4.2.9

In Vivo reconstruction

A patient was recruited, with written informed consent according to a research ethics
protocol, approved by the Western University Health Science Research Ethics Board
(HSREB) (protocol ID R-20-069). The volunteer was injected with 462MBq of 18F-FDG
tracer for a PET/CT scan first, and then the PET/MRI scan was started 3 hours and 15
minutes later. However, none of the PET/CT data was used in this study. Simultaneously
with a two-point Dixon acquisition, as described earlier, a 3D PET acquisition was
performed using the same parameters as those used for the TX-scans. A set of
cardiovascular MRI scans were acquired, but we report here only on two acquisitions
related to this study and analysis. A 2D axial half-Fourier single-shot turbo spin-echo
(HASTE) MRI was acquired using imaging parameters TR/TE = 1000ms/82ms, 20 slices,
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slice thickness (ST) = 6mm, matrix = 256x154, FOV = 380x380mm and flip angle (FA) =
139°.
Positions of TX-based maps for subject, table and array were matched. This is done by
acquiring the in vivo image at the center of a known location, between S2 and S3, same as
the table and array regions used in calculating the TX-based LAC. In-vivo PET list-mode
data was reconstructed offline with the TX-based AC maps for both posterior array and
patient table, using the e7-tools software. The AC images produced offline were analyzed
and compared to the vendor-provided, CT-based AC images produced by the PET/MRI
system itself.

4.2.10

Data analysis

In all analysis, hardware NAC data was compared to blank NAC data and hardware AC
data was compared to blank AC data, while for in vivo imaging, TX-based AC was
compared to CT-based AC. Hardware images reconstructed from the TX-based AC map
were quantitively compared to its corresponding CT-based AC images and blank images
using relative percentage difference (RPD) defined voxel-wise as (Blankdata – CTbaseddata / Blankdata) *100% and (Blankdata – TX-baseddata / Blankdata) *100%.
Furthermore, distribution of photon counts was examined using histogram analysis. In
order to examine the effect of both TX-based AC and CT-based AC on cardiovascular
quantification,17-segment polar plots of short-axis PET images were produced according
to the American Heart Association (AHA) standard for cardiac polar plots30. The segment
values, which cover from base to apex of the heart, were compared for both AC techniques.
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All computation of this work was performed using Matlab 9.7.0.13 (The MathWorks,
Natick, MA, USA).

4.3
4.3.1

Results and discussion:
TX-based AC map and validation of LAC

The TX-based procedure described in this work produced an AC map of the cylinder
material with an average LAC of 0.10851± 0.00380 cm-1. The theoretical Z-based LAC
derived form the chemical composition of acrylic described by29 was estimated to be
0.10698 ± 0.00321 cm-1. The coefficient of determination of the fitted 4th order polynomial
function is calculated to be R2 =0.9995. The percentage difference between the
theoretically derived LAC and measured LAC, using TX-based technique, was found to be
1.3±0.3% which was not statistically significantly different (p=0.7060).
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Figure 4-4: Theoretical estimation of acrylic material from mapped LAC values from
0.1 to 1.0 MeV.

The fitted model (R2=99.95%) produced LAC of acrylic at 511keV = 0.10698 cm-1 as
indicated with the red dashed lines.

4.3.2

TX-based AC, and CT-based AC for hardware

Figure 4-5 shows the line profiles, from the center of the PET image resulted from scanning
the Ge-68 rod with and without different hardware in the PET-FOV. The line profiles are
arranged in three clusters, each is related to the hardware under examination and includes
a line profile for NAC PET and two-line profiles for AC PET reconstructed with TX-based
and CT-based methods. The cylinder scans produced the line profile seen in figure 4-5-a
and represents NAC PET, the TX-based AC PET reconstructed offline and, CT-based AC
PET (produced by the CT scanner in a separate CT scan of the cylinder), respectively. The
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RPD values comparing the two AC PET reconstructions are reported in table 4-1, where
TX-based AC PET mean and standard deviation (std) was different from blank by 0.4±1.4
%, while the RPD of mean values in the case of CT-based AC was -1.9 ±0.8 %.
Figure 4-5-b, shows the NAC and both AC PET line profiles from the posterior array
results using the TX and the CT-based AC correction. As reported in table 4-1, the TXbased AC map, for posterior array, produced PET images with RPD of 0.5±1.5%, while,
CT-based AC produced RPD of 0.7±0.5%. The posterior array was estimated to attenuate
about 1.6±0.6% comparing between NAC of the posterior array and the NAC of blank. In
figure 4-5-c, the results from the patient table are showing the NAC data compared to both
AC techniques. Table 4-1, reported the RPD value between the NAC PET of the patient
table, and the NAC PET of the blank, which was found to be 8.7±1.2%, which is consistent
with what has been reported earlier6. For the patient table TX-based AC reported to produce
global mean RPD of -0.7±1.4% while for the CT-based AC the RPD was -4.3±1.3%.
In general, figure 4-6 shows both quantitative and qualitative analysis of both TX-based
and CT-based AC PET data and comparison to blank data. In figure 4-6 (a, c, and e) the
RPD, between blank images and its corresponding images of each AC technique or NAC,
are displayed for each transaxial plane number. In figure 4-6 (b, d, and f) the distribution
of photon counts per second and their frequency for each hardware; acrylic cylinder,
posterior array and patient table, respectively, are shown by histogram plot. Notably, the
CT-based AC PET distribution displays more frequent counts per second at lower values,
over TX-based AC PET. Likewise, the distribution of TX-based AC PET is closer to those
produced from blank in the case of the patient table, although this might not be apparent
(fig. 4-6-f), as the dashed red line belonging to CT-based plot are only covered by the
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black lines of the blank data. The percentage mean difference between AC and NAC blank
were estimated to be in the range of 11 to 18%.
Figure 4-5: Line plot of a profile from pixels centred on the PET image for the threehardware.

For the three-hardware configurations examined in this study, left line plot results
from acrylic cylinder with NAC PET, TX-based AC PET, CT-based AC PET, and
blank (black-dashed line). The same order of plots is repeated for the posterior array
and patient table respectively.
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Figure 4-6: RPD of NAC, TX-based AC and CT-based AC PET images for the
hardware under examination.

The RPD of NAC, TX-based AC and CT-based AC PET images for the acrylic cylinder,
posterior array, and patient table are shown in (a), c) and e)) respectively, compared to
blank. Distribution of photon counts are displayed in histograms in (b), d) and f)) comparing
TX-based AC to CT-based AC and blank
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Table 4-1: Relative percentage difference for non-corrected and corrected images of
hardware for TX-based AC and CT-based AC methods.

NAC

TX-based AC CT-based AC

TX-to-CT

mean ± std

mean ± std

mean ± std

mean ± std

Acrylic Cylinder

2.2±1.1

0.4±1.4

-1.9 ±0.8

-

Posterior array

1.6±0.6

0.5±1.5

0.7±0.5

-

Patient table (S2-S3)

8.7±1.2

-0.7±1.4

-4.3±1.3

-

-

-

-

4.1±0.9

In-vivo

RPD for NAC and AC images of hardware scan to NAC and AC image of blank
scan. In-vivo data from TX-based AC and CT-based AC are compared.

4.3.3

In-Vivo data

The AC PET images reported here are products of reconstruction with hardware AC maps
(posterior array and patient table) and the patient MRAC map determined by segmentation
of fat/water Dixon MRI. Both PET and 2D-HASTE MRI images are fused in figure 4-7,
using hardware TX-based AC (fig. 4-7-a) and CT-based AC (fig. 4-7-b). The CT-based
AC map and TX-based AC map of the patient table are displayed with the same scale in
figure 4-7 (a and b), respectively. In figure 4-8-a, the RPD map produced from both CTbased and TX-based PET data shows higher RPD values towards the posterior region. The
RPD between the TX-based and CT-based maps is displayed in figure 4-8-b.
In figure 4-9, a polar plot of the LV PET images is shown for TX-based AC (fig. 4-9-a)
and CT-based AC (fig. 4-9-b), respectively. We estimated the difference between CT139

based and TX-based attenuation-corrected PET images for the following regions: Apex,
Apical, Mid and Basal which are represented by the four circles of the polar plot, from
inward to outward, respectively. The RPDs for these regions were Apex -3.1±1.2%, Apical
1.5±1.1%, Mid -3.4±1.0% and Basal 1.2±1.1%.
Figure 4-7: Fused images of 1H/FDG for a volunteer, using TX-based and CT-based
µ-maps of the patient table.

Above, the fused images (a and b top) of the 2D-HASTE MRI to 18F-FDG PET for a
volunteer. a) is the offline reconstructed PET with the scanner using hardware TXbased maps (both, patient table and posterior part of the array), while b) is for the
same PET data, reconstructed using hardware CT-based maps. The lower row of the
figure (c and d), shows respectively, the TX-based and the CT-based maps of the
patient table
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Figure 4-8: RPD map of in vivo PET data resulted from comparing TX-based AC to
CT-based AC and RPD map of the hardware AC maps.

RPD map resulted from comparing in-vivo images reconstructed using TX-based AC
to CT-based AC shown in figure 4-7 (a, b); b) is the RPD map of the hardware AC
maps displayed in figure 4-7 (c, d).
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Figure 4-9: Polar plot of 17-segment for the LV short-axis of the heart, using TXbased AC and, CT-based AC.

4.4

Discussion:

Hardware attenuation correction based on PET transmission scans, is well established and
was applied using the PET/MRI scanner with two different techniques31,32. The technique
reported by Kawaguchi et al. was for the brain and it was not applied to hardware. The
group suggested the need for additional techniques to incorporate MR-invisible hardware.
Additionally, tissue segmentation was an issue in Kawaguchi’s work due to the three
unknowns of tissue textures in the formulation. Another TX-based technique was
performed by32 using a fixed radioactive source (Ge-68 cylinder) where they reported
improved of AC of the patient table from 4.5% (CT-based AC) to 2.7% (TX-based). Their
technique considered derivation of the LAC from two-point projection but they used a nonuniform TX source.

142

In this work, we utilized Lambert’s law, as a technique to estimate LAC at 511keV of
acrylic material with known theoretical value of LAC for validation. We simplified the
technique by providing a uniform source (Ge-68 rod), the hardware profile, its voxel
position and estimated partial path length which was used in LAC estimation. The TXbased method described here, was used to estimate AC maps for the posterior part of a
phased array RF coil, and the patient table, at the regions used for simultaneous PET/MRI
cardiac imaging. The maps produced from the TX-based technique were used, instead of
CT-based AC, to reconstruct PET images of a volunteer offline. TX-based AC and CTbased AC for hardware has shown that PET images resulted from TX-based AC differed
by less than 1% compared to the blank “truth” for all hardware cases.
The hardware used for TX-based AC was homogeneous enough, density-wise, to consider
the formulation for only one unknown, which might not be the case for hardware that has
larger areas with multiple densities. This technique also requires the knowledge of the
hardware position and profile and hence it is effective for fixed hardware, but might not be
as effective for mobile/flexible hardware.
The coefficient of determination of the polynomial fit (R2=0.9995) provides confidence in
the interpolated LAC value derived from mapped energies, while the RPD between the
theoretical and TX-based measured LACs validated both the acrylic cylinder attenuation
coefficient and, the technique for further work. The difference between NAC and AC from
the blank PET image suggests that the AC procedure performed on the NAC data,
compensates for scatter corrected AC PET verses non-scatter corrected NAC PET. We also
considered that the difference might represent the scatter and attenuation errors estimated
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by the system. Therefore, the AC data of the blank was the baseline that we used in the
analysis and for comparison.
It is worth noting here that both partial volume effect and positron long range of the Ge68, have no effect on the results. Since both effects are more observed within tissues, while
the derived LAC from TX-based depends on the number of LOR crossing the voxels of the
hardware AC map rather than on imaging pixels within the rod itself.
The negative RPD value between the blank and the acrylic CT-based AC images indicates
overcorrection of the CT-based AC compared to the TX-based AC. This also suggests that
CT-based AC of patient table is inaccurate compared to AC PET data from the blank scan.
The more frequent counts observed at lower value in figure 4-6 (b, d, and f) may be
interpreted as increased scattering artifacts, which may also explain the overcorrecting
behavior by CT-based AC for hardware that is previously reported in the literature 6.
Meanwhile, the RPD resulting from the comparison of in-vivo PET images reconstructed
by both methods, suggests that CT-based AC is less accurate than the TX-based AC, which
is quantified by mean RPD of 4.1±0.9% and reported in table 4-1.
Although this work targeted a specific region of the patient table used in cardiac imaging,
the technique can be employed to produce an AC map for the entire table, or other targeted
regions of the body. In our future work we will be reporting on the development of an AC
map for the full table.
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4.5

Conclusion:

The TX-based AC technique described in this study resulted in similar or improved
attenuation corrected PET images compared to CT-based AC. All TX-based AC produced
mean RPD of <1%, when compared to blank data. Although the cardiac results from a
patient reported here are encouraging, with changes in RPD of in-vivo PET matching the
improvements observed in phantom, more patients / volunteers would benefit statistical
analysis. The AC maps results from the three different types of hardware demonstrated a
consistent result, that is, the current CT-based AC for hardware using a bilinear model is
modestly inaccurate.
Here, we have shown that the generation of TX-based AC maps using a static radioactive
source and the PET/MRI system itself, for fixed hardware, is feasible. The strength of this
work is that the technique allows PET and PET/MRI research sites, where access to CT or
PET/CT systems is limited, to still produce highly accurate AC maps for their hardware.
The TX-based hardware AC map generated using the PET/MRI system also reduces time
and effort in comparison to using CT or PET/CT systems to generate hardware AC maps.

4.6

Acknowledgments:

The authors gratefully acknowledge: Dr. Udunna Anazodo for utilizing the PET data
acquired under protocol ID 6319. The authors also thank Ms. Chantelle Graf for recruiting
the patient, and both Mr. John Butler and Ms. Heather Biernaski for performing patient
PET/MRI scan. The authors also acknowledge: Funding from MITACS (Application Ref.

145

IT12869) (to JThé), an industry-sponsored internship (to AF) in collaboration with Multi
Magnetics Inc (London, Ontario, Canada). Partial salary support of AF by NSERC
Discovery Grant (No. RGPIN-2016-05055) (to JThé), infrastructure support by Ontario
Research Fund (RE07-021) (to FSP) and by Canada Foundation for Innovation Grant
(11358) (to FSP).

4.7

Reference

1.

Nensa F, Bamberg F, Rischpler C, et al. Hybrid cardiac imaging using PET/MRI:
a joint position statement by the European Society of Cardiovascular Radiology
(ESCR) and the European Association of Nuclear Medicine (EANM). European
Journal of Hybrid Imaging. 2018;2(1):14.

2.

O’ Doherty J, Chalampalakis Z, Schleyer P, Nazir MS, Chiribiri A, Marsden PK.
The effect of high count rates on cardiac perfusion quantification in a simultaneous
PET-MR system using a cardiac perfusion phantom. EJNMMI Physics.
2017;4(1):31.

3.

Wisenberg G, Thiessen J, Pavlovsky W, Butler J, Wilk B, Prato F. Same day
comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis. Journal
of Nuclear Cardiology. 2019:1-12.

4.

Wilk B, Wisenberg G, Dharmakumar R, Thiessen JD, Goldhawk DE, Prato FS.
Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
Journal of Nuclear Cardiology. 2019.

146

5.

Lindemann ME, Guberina N, Wetter A, Fendler W, Jakoby B, Quick HH.
Improving 68-Ga-PSMA PET/MR hybrid imaging of the prostate with unrenormalized absolute scatter correction. Journal of Nuclear Medicine. 2019.

6.

Fürst S, Souvatzoglou M, Martinez-Möller A, Schwaiger M, Nekolla SG, Ziegler
SI. Impact of flexible body surface coil and patient table on PET quantification and
image quality in integrated PET/MR. Nuklearmedizin, Georg Thieme Verlag KG.
2014;53(03): 79-87.

7.

Aklan B, Paulus DH, Wenkel E, et al. Toward simultaneous PET/MR breast
imaging: Systematic evaluation and integration of a radiofrequency breast coil.
Medical physics. 2013;40(2):024301.

8.

Dregely I, Lanz T, Metz S, et al. A 16-channel MR coil for simultaneous PET/MR
imaging in breast cancer. European Society of Radiology. 2014;25:1154–1161.

9.

Farag A, Thompson RT, Thiessen JD, Biernaski H, Prato FS, Théberge J.
Evaluation of 511 keV photon attenuation by a novel 32-channel phased array
prospectively designed for cardiovascular hybrid PET/MRI imaging. European
Journal of Hybrid Imaging. 2020;4(1):7.

10.

Kartmann R, Paulus DH, Braun H, et al. Integrated PET/MR imaging: Automatic
attenuation correction of flexible RF coils. Medical physics. 2013;40(8):082301.

11.

MacDonald LR, Kohlmyer S, Liu C, Lewellen TK, Kinahan PE. Effects of MR
surface coils on PET quantification. Medical physics. 2011;38(6):2948-2956.

12.

Paulus DH, Braun H, Aklan B, Quick HH. Simultaneous PET/MR imaging: MRbased attenuation correction of local radiofrequency surface coils. Medical physics.
2012;39(7):4306-4315.

147

13.

Tellmann L, Quick H, Bockisch A, Herzog H, Beyer T. The effect of MR surface
coils on PET quantification in whole-body PET/MR: results from a pseudoPET/MR phantom study. Medical physics. 2011;38(5):2795-2805.

14.

Galldiks N, Langen K-J. Amino acid PET in neuro-oncology: applications in the
clinic. In: Taylor & Francis; 2017.

15.

Bailey DL. Transmission scanning in emission tomography. European Journal of
Nuclear Medicine. 1998;25(7):774-787.

16.

Carroll LR, Kretz P, G. O. The orbiting rod source: improving performance in PET
transmission correction scans. New York: Society of Nuclear Medicine. 1983(In:
Esser PD, ed. Emission computed tomography – current trends.):235–247.

17.

deKemp RA, Nahmias C. Attenuation correction in PET using single photon
transmission measurement. Medical physics. 1994;21(6):771-778.

18.

Burger C, Goerres G, Schoenes S, Buck A, Lonn A, von Schulthess G. PET
attenuation coefficients from CT images: experimental evaluation of the
transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med
Mol Imag. 2002;29(7):922-927.

19.

Carney JP, Townsend Dw Fau - Rappoport V, Rappoport V Fau - Bendriem B,
Bendriem B. Method for transforming CT images for attenuation correction in
PET/CT imaging. American Association of Physicists in Medicine. 2006;33(4):976983.

20.

Guy MJ, Castellano-Smith IA, Flower MA, Flux GD, Ott RJ, Visvikis D.
DETECT-dual energy transmission estimation CT-for improved attenuation
correction in SPECT and PET. IEEE Transactions on Nuclear Science.
1998;45(3):1261-1267.

148

21.

Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a
combined 3D PET/CT scanner. Medical physics. 1998;25(10):2046-2053.

22.

Patrick JC, Terry Thompson R, So A, et al. Technical Note: Comparison of
megavoltage, dual-energy, and single-energy CT-based μ-maps for a four-channel
breast coil in PET/MRI. Medical physics. 2017;44(9):4758-4765.

23.

Ghadiri H, Shiran MB, Ay MR, Soltanian-Zadeh H, Rahmim A, Zaidi H. A novel
energy mapping approach in CT-based attenuation correction of PET data using
multi-energy CT imaging. Paper presented at: 2011 IEEE Nuclear Science
Symposium Conference Record; 23-29 Oct. 2011, 2011.

24.

Shirmohammad M, Ay MR, Sarkar S, Ghadiri H, Rahmim A. Comparative
assessment of different energy mapping methods for generation of 511-keV
attenuation map from CT images in PET/CT systems: A phantom study. Paper
presented at: 2008 5th IEEE International Symposium on Biomedical Imaging:
From Nano to Macro; 14-17 May 2008, 2008.

25.

Witoszynskyj S, Andrzejewski P, Georg D, et al. Attenuation correction of a flat
table top for radiation therapy in hybrid PET/MR using CT- and 68Ge/68Ga
transmission scan-based μ-maps. Physica Medica. 2019;65:76-83.

26.

Mollet P, Keereman V, Bini J, Izquierdo-Garcia D, Fayad ZA, Vandenberghe S.
Improvement of Attenuation Correction in Time-of-Flight PET/MR Imaging with
a Positron-Emitting Source. Journal of Nuclear Medicine. 2014;55(2):329-336.

27.

Aklan B, Oehmigen M, Beiderwellen K, et al. Impact of Point-Spread Function
Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging. Journal
of Nuclear Medicine. 2016;57(1):78-84.

149

28.

Comtat C, Bataille F, Michel C, et al. OSEM-3D reconstruction strategies for the
ECAT HRRT. Paper presented at: IEEE Symposium Conference Record Nuclear
Science 2004.; 16-22 Oct. 2004, 2004.

29.

Hubbell JH. Tables of X-ray mass attenuation coefficients and mass energyabsorption coefficients from 1 keV to 20 MeV for elements Z=1 to 92 and 48
additional

substances

of

dosimetric

interest.

http://wwwnistgov/pml/data/xraycoef/indexcfm. 1982.
30.

Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized Myocardial
Segmentation and Nomenclature for Tomographic Imaging of the Heart.
Circulation. 2002;105(4):539-542.

31.

Kawaguchi H, Hirano Y, Yoshida E, et al. A proposal for PET/MRI attenuation
correction with μ-values measured using a fixed-position radiation source and MRI
segmentation. Nuclear Instruments and Methods in Physics Research Section A:
Accelerators, Spectrometers, Detectors and Associated Equipment. 2014;734:156161.

32.

Xie H, Zhao J, Dong Y, Lv Y. Attenuation Correction for Fixed MR Components
in a Simultaneous PET/MR System. Paper presented at: 2017 IEEE Nuclear
Science Symposium and Medical Imaging Conference (NSS/MIC); 21-28 Oct.
2017, 2017

150

Chapter 5
5

Conclusion and future work

5.1

Summary

The overall goal of the thesis was to improve sensitivity and quantitative accuracy of
cardiac PET when PET data is collected simultaneously with the whole-body hybrid
PET/MRI imaging system. An important point is that this is to be achieved without
diminishing the performance of the MRI. To achieve this, three objectives were formulated
which were realized using two novel “inventions”, the three objectives are:
a) Objective 1: characterize a high-density RF phased array with MRI performance
similar to dedicated cardiac phased array on MRI-only platform.
b) Objective 2: incorporate into this array a design features which would dramatically
reduce PET signal attenuation compared to dedicated cardiac RF arrays on both
MRI-only and PET/MRI platforms.
c) Objective 3: develop a technology that will allow accurate determination of the
511keV attenuation coefficients of hardware that is used for accurate quantitative
of PET signal that can be achieved without the need of x-ray CT.
This was achieved through two novel inventions:
a) Novel invention 1: the software and hardware developed to complete the
characterization of the prospectively-designed, novel 32-channels phased array
cardiac dedicated RF phased array and its implementation address objectives 1 and
2.
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b) Novel invention 2: redesign, manufacturing and implementation of a method using
a static radioactive line source to generate an accurate attenuation correction map
of rigid hardware using the hybrid PET/MRI system itself without the need for CT
scanners.
While achieving the first objective, the issue of misregistration of µ-map of the phased
array flexible parts is eliminated. This is determined by the negligible photons attenuation
of true counts produced by the flexible part of the novel array. Nevertheless, the need to
address accurate attenuation correction µ-map for rigid hardware is also recognised. Hence,
the new approach, based on transmission scan of a static radioactive source, was developed
and evaluated for the patient table and the rigid, and attenuating, part of the RF array. The
novel TX-based approach, using the PET/MRI system, has two advantages; any site that
has the hybrid PET/MRI system can create the desired hardware maps, and the generated
maps are free of beam hardening artifact typically introduced by the CT scanning of the
hardware.

5.2
5.2.1

Conclusions
Chapter 2

The MRI performance of the novel prospectively-designed PET/MRI 32-channel array
qualifies it to be a viable alternative to the conventional arrays for cardiovascular hybrid
PET/MRI. The SNR at different acceleration factors (R > 2) were better on average by 30%
than the receivers’ array currently used in cardiac PET/MRI.
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5.2.2

Chapter 3

Results of this novel 32-channel cardiac array PET performance evaluation, together with
its reported MRI performance assessment in chapter 2, suggest that the novel array is a
strong alternative to the standard arrays currently used for cardiovascular hybrid PET/MRI
imaging. It enables accurate PET quantification and high-temporal and spatial resolution
for MR imaging.

5.2.3

Chapter 4

A new approach based on the transmission scan of a static radioactive source was
developed and evaluated for the patient table and the rigid part of the array. The LAC of
the acrylic cylinder measurements using the TX-based technique was in agreement with
those in the literature confirming the validity of the technique. The over-estimation of
photon counts caused by the CT-based model used for the patient table, was improved by
the TX-based technique. Therefore, TX-based AC of hardware using the PET/MRI system
itself is possible, and can produce more accurate images when compared to the CT-based
hardware AC in cardiac PET images.

5.3

Answering the research question

Several findings revealed during this work show promise in achieving accurate
quantification of PET while performing high temporal and spatial resolutions on MRI.
The goal of the redesign of the high-density RF phased arrays to suit PET environment has
been achieved. Although the prospectively-designed novel array was developed and tested
as a prototype, with no further improvements or iterations, the array performed
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exceptionally well. Therefore, developing high-density 32 channels RF array of
prospectively-designed for Cardiovascular PET/MRI is possible, which answers the first
research question listed at the end of the introduction of chapter 1.
While the flexible 6-channel vendor array is capable of producing acceleration images at
R=2 in the left-right encoding with less degradation to SNR, the novel array has still
achieved higher SNR than the vendor array at the same acceleration factor. At higher
acceleration factors, 3 and 4 specifically and at spatial resolution of 1x1x3 mm, the novel
array produced reasonable SNR for diagnostics, while the vendor arrays have noticeable
degradation of SNR and deemed unfit for diagnostics.
The above-mentioned spatial resolution, and at R=4 with no averaging, was achieved using
a TrueFisp sequence and the novel array within an acquisition time of 14 sec. This, together
with reasonable SNR at R=4, indicates the readiness of the novel array to provide high
spatial and temporal resolutions, which answers the second research question in chapter 1.
A few patients and volunteers were imaged with the array and with the same time and work
flow as the vendors array. A general trend of satisfaction is reported, which addresses the
third research question posed earlier in chapter 1.
Even with tripling the number of elements in the novel RF phased array, the attenuated
photons were in the range of -0.1% to 2%, much less than those produced by any of the
vendors arrays with lower number of channels. In fact, the anterior part of the novel 32
channel RF phased array produced an error less than the errors that would have been
produced having registered and applied its attenuation correction µ-map, and yet, no extra
time and computation were needed. The anterior part is therefore recommended to be used
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with no associated hardware attenuation correction map for AC image reconstruction.
These results provide an answer to research questions four, five and partially six.
Although the photon attenuation due to the posterior part of the novel array was in the
acceptable range of errors (< 3%), further attempts aiming to eliminate the beam hardening
effect that may affect the LAC estimation, encouraged development of a novel approach
(the TX-based µ-map). Besides developing TX-based hardware µ-map for the posterior
array, a TX-based hardware µ-map for the patient table was also developed.

The

quantification of reconstructed cardiac images using both CT-based µ-map and TX-based
µ-map has shown approximate 4% difference. The elimination of beam hardening effects
in the TX-based map were achieved, and this theoretically improves the accuracy of the
LAC, hence improving accuracy of the PET quantification. With these findings and
results, both research questions seven and eight are answered.

5.4
5.4.1

Impact of the work of the thesis
On cardiovascular imaging with PET/MRI

The availability of a 32-channel phased array prospectively-designed for PET/MRI
cardiovascular imaging, capable of acquiring an image fast, is a must.

Several

cardiovascular studies have shown the need for such tool to assist in both; reducing the
scan time (especially for cardiac patient who can not hold their breath for more than 10
seconds and when free-breathing sequences are not available); and to harness the PET
sensitivity by accurately quantifying tracer activities. Future broader availability of such
tools will facilitate the development of shorter and more quantitatively accurate
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cardiovascular imaging protocols. Additionally, the novel array provides improved spatial
and temporal resolution over the 12ch-array, which could be employed in 3D acquisitions,
such as, 3D cine imaging where cardiac and respiratory motions can be resolved in 3D.

5.4.2

On hybrid PET/MRI imaging modalities

The two novel approaches presented here were motivated by the need for elegant solutions
without unnecessary complexities. It is the author’s hope that similar paths will be followed
and explored in research and development. In specific terms, the expected impact is that
the redesign approach used in the development of the cardiac RF phased arrays presented
in this thesis will be used to improve other simultaneous hybrid PET/MRI hardware
components.
If brain, breast, thorax and other RF arrays are redesigned or developed with their
attenuation correction µ-map generated with non-CT-based methods, the accuracy of PET
quantification will improve, and hence confidence in the quantification-based diagnostic
of cardiovascular diseases (and others) by PET/MRI, is assured.
The novel TX-based AC method presented in this work simplifies the process of generating
LAC compared to what is normally performed using a rotating rod, which requires long
acquisition times. Furthermore, the method addresses once and for all the beam hardening
and bilinear transformations associated with the CT-based AC method for hardware used
with PET/MRI modality, hence AC for the tissue and others can be focused upon.

5.5

Future Work

The novel array results have shown the feasibility of such devices to exist for
cardiovascular and brain applications, however, for other parts of the body (i.e. prostate,
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thorax liver etc.) similar RF arrays are yet to be developed. Although the novel array was
developed for the Siemens Biograph mMR- PET/MRI scanner, the concept is transferable
to other vendor of PET/MRI scanners.
The TX-based AC technique should be applied to other hardware used with the PET/MRI
scanners, supported with independent study of their impact on PET quantification, and
statistical findings should be reported.
Complete patient table TX-based AC µ-map still needs to be developed, which requires
different techniques to include the full length of the table in one AC map.
Although hardware attenuation plays a role in inaccurate quantification of PET on a
PET/MRI system, motion induced inaccurate quantification is also important. Heart and
respiratory motion still require more elegant and fast solutions suitable for clinical settings,
without the need for offline algorithms for reconstruction and correction.
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Appendices
Appendix 1: Research ethic approval letter for human studies carried in chapter 2.
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Appendix 2: Research ethic approval letter for human studies carried in chapter 4.
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